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Abstract
The P300 component of the auditory EEG event-related
potential

(ERP) and

Positron Emission Tomography (PET)

were investigated in individuals considered to be early
cases of probable Alzheimer's type dementia (PAD) and a
control group of similar age.
investigated:

Two questions were

(a) The degree to which P300 latency was

sensitive to neurocognitive changes in very early stages
of PAD; and (b) The relationship between P300 latency and
specific areas of reduced neural functions as reflected in
PET scans.

A significant difference was found between PAD

and normal subjects in P300 latencies, with those in the
patient group having longer P300 latencies than the
control group.

The P300 latencies were significantly

correlated with cortical, but not subcortical, metabolic
rates.

The highest correlation was between P300 latency

and pareital PET scores, with other significant
correlations with P300 latency in the following order:
frontal,

temporal and parahippocampal.

These data

indicate that P300 latency is an index of the integrity of
association cortex and, as such, is sensitive to the very
early stages of Alzheimer's dementia.
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Dementia of the Alzheimer's type (OAT) is diagnosed
in at least one-half of all cases of dementia [19] but
nevertheless remains a difficult diagnosis to make with
confidence. This category of dementia is characterized by
atrophy of the cerebral cortex and dilation of cerebral
ventricles.

This change in the cerebral anatomy, though

often more marked, is not necessarily different than that
of normal aging.

Senile plaques and neurofibrillary

tangles, which are believed to be partially responsible
for the dementing process, are found in both demented and
non-demented persons, although usually in different
quantities.

The nucleus basalis appears to be responsible

for diffuse cholinergic projection to the cerebral cortex.
Significant cell loss has been reported [8] in the nucleus
basalis possibly acccounting for the cholinergice deficit
found in Alzheiemr's patients. The dependence upon
behavioral signs for the clinical diagnosis of OAT in the
living patient often causes confusion between the various
dementias, as well as between dementia and various other
conditions which have overlapping behavioral features,
such as depression.

Both anatomical and neurobehavioral

differences are obviously least distinct in very mild,
early stages of OAT when diagnoses are usually sought.
There is,

th~s,

a need for more precise and objective
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means of diagnosing Alzheimer~s dementia in the elderly.
The latency of the P300 component of the auditory eventrelated potential (ERP) has shown promise as a means of
evaluating cognitive functioning.
Marsh and Thompson [23] were perhaps the first to
report increases with normal adult aging in P300 latency
measurements using auditory discriminative tasks.

An

increase in latency was seen for normal elderly
individuals. A continuous linear or exponential increase in
P300 latency with adult aging has been demonstrated by a
number of investigators [5 ,17, 38].
The latency of the P300 increases further in most cases
of persons with a neurological disease which results in
dementia, whereas persons with functional disorders or
neurological disease without cognitive impairment rarely
exhibit an increase in P300 latency.

[4, 17, 38].

Thus

P300 latency measurements may prove to be an important
tool in the differential diagnosis between demented and
non-demented patients.
One possible cause for the occurrence of a P300
outside the normal range for some demented patients and
not for others could be the sensitivity of the P300
latency to cortical neural activity within specific
regions of the brain.

That is, regardless of the global

level of dementia, certain specific neural tissue must be
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dysfunctional for P300 latency to become abnormally

long~

The neural substrates for abnormal P300 latencies are not
known, that is, it is not as yet known whether or not the
abnormally prolonged latencies seen in dementia are
associated with functional deficits in specific brain
systems, structures, or regions.
With recent advances in Positron Emission Tomography
(PET), it is now possible to measure the metabolic
activity of specific brain regions in living, active
patients.

The earliest and most specific changes

occurring in diseases of the brain

hav~

been shown to be

reflected in disturbances of underlying biochemical
proce~ses

[32].

PET scans have recently been found to be
characteristically abnormal in cases of Alzheimer's
disease.

Kuhl et al.

[20] found that 2-deoxy-2-fluror-D-

glucose (FDG) scans in Alzheimer's type dementia revealed
abnormal metabolic patterns suggestive of neuronal
degeneration which was most severe in the cortex.

The

average decrease in zonal metabolism was 47% in parietal
and dorsolateral occipital cortex, and 28% in caudate and
thalamus.

There is ·a significant positive correlation

between cortical glucose use measured by the PET and the
Full Scale IQ, Verbal IQ and Performance IQ scores on the
Wechsler Adult Intelligence Scale in both normal and

P300 and PET
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demented patients [7].

It has been found that cerebral

glucose utilization is most dramatically reduced in the
posterior pareital cortex of DAT patients [15].

Cerebral

blood flow was also found to be markedly reduced in the
pareital and temporal regions for these patients [16].
This study investigated the relationship between PET
scan and P300 latency measures in individuals considered
to be early, mild cases of probable Alzheimer's type
dementia (PAD) in order to determine the relationship of
P300 latency increase to specific regional changes in
brain metabolism.

I~

was hypothesized that:

(a)

P300

latency is a reflection of brain integrity which will be
manifested in PET indices of metabolic rate.

(b) P300

latency will reflect most strongly neocortex and/or
archecortex metabolic rate and less metabolic activity of
subcortical regions.

(c) P300 latency will be relatively

longer in patients with reduced parietal and/or temporal
metabolic rate.
Method
Subject Evaluation
A very large group of possible subjects was recruited
from the community via letters sent to area physicians,
neurologists and psychiatrists asking for referrals of
normal controls and persons with early signs of memory and
intellect problems.

The research program was also
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announced in local newspapers, trade journals and on radio
and television interviews.
Each potential subject was given an initial
assessment to determine if s/he met standardized intake
criteria of early dementia and to exclude those not
meeting these criteria or alternatively, consider them for
the control group.

An interviewer gathered information

regarding educational and occupational background, and
medical or neurological history.

Part of this information

was obtained from a second source who knew the subject
well.

A brief standardized test of cognitive and

functional abilities, the Mini-Mental state (MMS; Appendix
F)

[13], was completed. The significant other of the

patient was asked to rate the patient (on a 7 point scale)
in daily functions of remembering, problem solving,
clinical signs, and home activities using the Dementia
Scale [2] with inclusion criterion being a score of equal
to or less than 10.

The Zung Self Rating Depression Test

was also given with a score of less than 60 excluding the
patient from this study.

A score between 2 and 6 on the

partial Hachinski Ischemic Scale ·(Appendix G) was taken as
a sign of possible dementia, a score of 7 or greater
suggested possible multiple infarct dementia and excluded
the patient.

P300 and PET
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Following the initial assessment, a more thorough
dementia evaluation was completed to establish a
preliminary diagnosis.

A full medical, psychiatric and

social history was obtained.

Further tests included

complete neuropsychological and neurolinguistic
evaluations.

The degree of memory impairment was

assessed, cognitive status was fully evaluated and the
presence of aphasic or apraxic signs noted.

In order to

be included in the study each patient earned scores as
follows:

WAIS Digit Span (forward and backward) with a

score equal to or less than 8, the Word Generation Test
(less than 12 in 1 minute), and Rey's Visual Scanning
Tests [36]

(less than 18 words in one minute, i.e. the

25th percentile) .
The final stage of subject evaluation involved a
series of medical laboratory tests to rule out sources of
cognitive impairment other than DAT.
included:

Medical tests

chest x-ray, electrocardiogram, urinalysis,

erythrocyte sedimentation rate, full screening blood
panel, B12, folate, and thyroid function tests.

Tests to

assess organic brain syndrome included EEG, MRI and CT
Scans.
The control group consisted of 17 individuals 52-71
years of age who agreed to participate as volunteers.

All
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individuals in the control group earned a Mini-mental
State score of 28-30 and fell within the normal range on a
battery of neuropsychological tests.
The patient group consisted of 32 individuals 56-76
years of age with a score on the Mini-mental state between
20-27. Their scores on the neuropsychological battery fell
below the normal range, and they exhibited behavioral
symptoms congruent with a diagnosis of mild dementia.
Patients were divided into two subgroups according to
Clinical Diagnostic Ratings (CDR; see Appendix E)
0.5 and 1.0.
respectively.

[19] of

This constitutes possible and probable OAT,
The CDR utilzes information gathered

through interviews to determine the stage of dementia a
patient has reached.
assessed including:

Six categories of functioning are
memory, orientation, judgment/problem

solving, community affairs, home/hobbies and personal
care.
P300 Recordins
For P300 recording, EEG electrodes were fixed with
~lec~rolyte paste at the Fz, Cz, Pz sites on the patient's

head (International 10-20 Electrode System). Ear clips
were used for reference and ground. Subjects were seated
in an electrically shielded, sound attenuating room for
EEG recording, and headphones placed over the patient's

P300 and PET
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ears.

An attendant was in the recording room with the

subject at all times.
An "auditory oddball" stimulus paradigm was utilized
with frequent tones (250 Hz, 70db SPL, 60 msec duration)
occurring on 80% of the trials and target tones (450 Hz,
84db SPL, 60 msec duration) occurring on 20% of the
trials.

One tone was heard every 1.5 seconds until a

total of 32 artifact free responses to the target tone
were recorded.

Responses spoiled by muscle or eye

movement artifact were rejected automatically by the
averaging computer according to an amplitude threshold
adjusted for each individual subject.

Each subject was

asked to listen to the tones as they were presented and
instructed to count silently the louder, higher pitch tone
(target tone), and ignore the softer, lower pitch tone.
The attendant informed the subject that periodically the
tones would be stopped and a count asked for from the
subject.

Following these instructions, a short trial

segment was presented in order ,to determine that the
subject understood the instructions and was able to
discriminate between the two tones and do the task.

In

the event that the . subject was unable to keep an internal
count, s/he was instructed to lift her/his index finger at
the sound of the target tone.

If necessary, this skill

was shaped during practice trials by the attendant,
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indicating to the subject when to lift a finger.

When it

was determined that the subject was prepared for the task,
two runs were completed with a short break in between
runs.

For this study, six patients were unable to keep

an internal count, and the shaping technique was utilized.
Each of these six patients had an initial CDR of 1.0 and a
P300 z-score which exceeded 2 SD beyond the mean.
For each recording locus, event-related potentials
were amplified (Gain= 14,000, Bandpass= .1-50Hz),
digitized (250 samples/sec) and separately averaged for
the frequent and target stimuli.

Average ERPs spanned

1000 msec, including a 100 msec prestimulus epoch.
Average responses were stored on computer disks and
plotted on an X-Y plotter immediately following a run.
For each electrode derivation, plots include the ERP to
the frequent and target stimulus, and the difference
between these potentials for reasons explained below.
P300 latencies were measured at PZ, CZ, and FZ sites.
The P300 component was identified as the first positive
peak after 250 msec.

Where a single peak does not appear,

but rather a flat-top or multiple peak waveform, a midwave
measurement was made.

Scalp topography and difference

waveforms (i.e. target minus frequent) were used as aids
in identifying the P300 wave.

P300 and PET
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Since P300 latency in this paradigm increases
progressively with normal aging [5], z-score deviation
from the age/P300 latency function adjusted for this
effect on the basis of a larger normative group.

The P300

latency measures at Cz were expressed in z-scores in
reference to the age/P300 latency regression function
derived from a very large group (N= 71, 57 < 40 years of
age) of normal, elderly individuals previously recorded
using the same task and recording procedures.
PET Scan
Each patient and control underwent a glucose
utilization Positron Emission Tomography (PET) scan which
involved the injection of F-18 labeled 2-deoxy-2-fluror-0glucose (FOG).

An extension of Sokoloff's OG model for

measuring local cerebral metabolic rate of glucose in
autoradiography, which included the dephosphorylation
reaction, was applied to this PET study.
For comparison between groups and individuals, PET
FOG values were expressed as ratios of different brain
areas in order to adjust for variability in absolute
metabolic measure between individuals.
subcortical PET

FO~

Cortical and

values were expressed as ratios with

cerebellar values, a structure found to be relatively
stable in mild to moderate OAT.

Studies have found

that

P300 and PET
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such ratios are less variable in demonstrating regional
differences in metabolic rate [27].
Results
The groups admitted for study were not significantly
different in age compared either between normals and
possible Alzheimer's dementia (PAD) or between the 3 CDR
groups (CDR 0, 0.5 and 1.0).
Figure 1 gives an example of the actual ERPs recorded
from two PAD patients and controls.

The shaded areas

demonstrates the P300 component obvious in the difference
between the response to the frequent and the rare stimuli.
It can be seen that the P300 for the PAD patients are
significantly longer than for the control.
Insert Figure 1 about here
Figure 2 presents the P300 latency z-scores for the
normal control and two PAD groups.

It can be seen that

while all the normal patients fell below +1.5 SD of the
normative group, 27 of 32 PAD patients exceeded norms by
more than +2 SD.

Remarkably, despite relatively mild PAD

in the two patient groups, P300 latencies were grossly
abnormal in a large number of cases.
Insert Figure 2 about here
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There was a significant difference in P300 latency zscores between the combined PAD group and the control
group (p < 0.0005) and between the three CDR groups
compared separately (p< 0.0005). The mean P300 measure for
those with a CDR of 0 (normals) is significantly lower
than those with a CDR rating of either .5 or 1.0 (p<
0 . 00 3 )

(see Tab 1 e 1 ) .
Insert Table 1 about here

There is, however, no significant difference in P300
latency z-score between those with a CDR of 0.5 and
those with a CDR of 1.0 (see Table 1).
A significant correlation was found between MMS
and P300 z-scores (r= -0.59, p < 0.0005) for the three
groups combined.

As P300 latencies become longer, there

is a decline in MMS scores.

However, again within the

patient groups, the P300 latency/MMS correlation was not
significant (r= -0.21, n.s.).
There was a significant negative correlation between
P300 latency and cortical PET FDG ratios in the combined
control and PAD groups.

Specifically, there was a

significant correlation demonstrated between P300 z-scores
and Parietal/Cerebellum (p < 0.001); and
Frontal/Cerebellum (p < 0.001); Temporal/Cerebellum (p <
0.003); and Para-hippocampal/Cerebellum (p < 0.004) FDG

P300 and PET
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ratios (see Figure 3).

Thus, decrease in relative

cortical metabolic rate for these structures was
associated with a long P300 latency. There was no
significant correlation with P300 latency for Caudate
Thalamus/Cerebellum ratios or for the global measure of
FDG uptake ratios (see Figure 3).

This correlation was

Insert Figure 3 about here
essentially carried by the pareital/cerebellum ratio.

The

frontal, temporal and parahippocampal ratios contributed
only 0.12 combined.
When P300 and PET measures were compared within only
the PAD patients there was a significant correlation (p <
0.006)

for the Frontal/Cerebellum FDG ratio.

There was no

significant correlation for any of the other FDG ratios.
(see Figure 4) .

There were no significant PET/P300

latency correlations when compared only within the control
group (see Figure 4) .
Insert Figure 4 about here
Discussion
These data demonstrate a number of important
points about P300 latency in Alzheimer's type dementia.
First, the data indicate that the P300 latency is
sensitive to very early, mild forms of DAT.

In this

P300 and PET
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sample of carefully diagnosed and screened, but marginally
demented PAD subjects, 85% showed prolonged P300 latency
at clinically detectable levels (i.e. > +1.5 SO).
Although P300 does not discriminate within the PAD group
(between CDR 0.5 and CDR 1.0), there is a significant
difference in the P300 latencies even between the control
and the 0.5 CDR group (i.e. those with only "possible"
Alzheimer's dementia).

Sensitivity of P300 to mild

dementia was also seen in the significant correlation
between P300 latency and MMS over a moderate range of MMS
scores

(i.e. >20) and P300 latencies.

These data are

thus consistent with the results of studies by Lai [21],
and Brown, Marsh and LaRue [5].
Recent literature [31, 33] has brought into question
the clinical usefulness of the P300 latency in the
diagnosis of dementia.

It was suggested that the P300 is

only able to accurately detect major cognitive deficits,
and would produce too many false negatives for persons
with early, mild forms of dementia and too many false
positive among "non-demented" psychotic individuals.
Pfefferbaum et al.

[31] used a more difficult paradigm

with two infrequent stimuli and a wider standard deviation
range, a standard error of regression being amost twice
that of Goodin et al.
than other studies.

[17], in the normative aging data
They found 20 to 30 percent of their
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schizophrenic patients had P300 latencies which fell more
than 2 SD above the mean while fewer that one/half of the
P300 latencies of the demented group fell two or more SD
beyond the mean for their age.

In the Brown et al.

[4]

study there were no false positives meaning that no nondemented person was classified as demented using the P300
latency.

They did find though that 7 of 26 demented

patients were misclassified as non-demented using a cutoff
of 2 SD beyond the mean for the patient's age.
al.

Polich et

[33] reported that 31 percent of the demented patients

fell 2SD beyond the age regression line and 54 percent
fell beyond 1 SD of the regression line. The present data
at least indicate that the P300 is sensitive to cognitive
deficit associated with early, mild probable Alzheimer's
disease.

The P300 latencies of the patients were in many

cases more than four standard deviations different from
the latencies of non-demented subjects of similar age.
The dramatic differences between groups in this study
may be due to the very careful screening of both patients
and controls.

Most other studies of this problem have

used mixed groups of dementias less well diagnosed and
screened [31, 33] . . It is possible that DAT differs from
other types of dementias in having relatively direct
effects on P300 latency.

Thus in a relatively pure DAT

group the association between P300 latency and dementing
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illness is stronger than found in studies including a less
homogeneous group.
A second major finding of this study is the
relationship between P300 latency and cortical metabolic
activity.

From this study it can be observed that the

P300 latency is a reflection of brain functional integrity
as revealed in PET measures.

Significant negative

correlations were found between P300 latency and PET
measures of metabolic rate.

As the metabolic rate of the

brain decreases, the P300 latency becomes longer.
P300 latency appears to reflect primarily cortical
metabolic activity.

The correlations between the PET

ratios and the P300 are significant for neocortical
structure (i.e. parietal, temporal, and frontal) and
archecortical

(parahippocampus)

structures of the brain.

However, P300 does not appear to be related to relative
subcortical metabolic rate, as manifested in PET measures
from the caudate/thalamus.

Nor is P300 latency associated

with global measures of whole brain metabolic activity.
From these data, it appears that the P300 latency is
specifically sensitive to a decline in the metabolic rate
of posterior brain regions, especially the pareital and
temporal areas.

These data correspond with the recent

studies of Foster et al.

[15] and Frachowiak et al.

[16]

of Alzheimer's patients which suggest that the pareital
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and temporal areas show the earliest decline in metabolic
rate with onset of the disease. Since a decline in
metabolic activity in these areas are suggestive of early,
mild Alzheimer's dementia, it can be suggested that the
P300 shows promise in being useful for the diagnosis of
early Alzheimer's dementia.
P300 latency reflects the time required to complete
demands of a task.

The more difficult the task, the

greater the time needed for completion.

The P300 latency

has been shown to be related to the processes associated
with stimulus evaluation independent of reaction time. [11,
27, 35].

This suggests that P300 latency is likely to be

dependent upon the neural systems of the posterior
pareital cortex which are involved in the perception,
analysis and discrimination of stimulus information.

This

would be consistent with the PET/P300 latency correlations
of this study.
Much of the discussion regarding the cognitive
significance of the P300 has focused on the relationship
between P300 and memory functions.

P300 amplitude has

also been found to correlate with new learning [22].

P300

amplitude was larger for learned items than new items but
smallest for overlearned items, whereas P300 latency was
longest for new items and shortest during overlearning.
The authors suggest that new items may results in a
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mismatch and updating of working memory or schema [10].
Memory span size nearly doubles between the ages of 5 and
12 years [34].

Miller [24] suggested that the size

increase stems from a change in the number of memory
"slots" available to store information.

It has been

hypothesized [6, 34] that this developmental increase in
memory capacity results in improvement in speed of mental
operation processing.

A relationship between memory

performance as measured by the Digit Span task and P300
amplitude has been found [18, 35], with better memory
performance correlated with P300 amplitude.
The P300 latency prolongation may reflect deficits in
the

~mmediate

memory of older patients, especially those

with a dementing disease.

Several studies [4, 17, 25, 38,

39] have found increased P300 latencies associated with
cognitive dysfunction for both young and old subject
populations.

Ford et al.

[14] suggested that the elderly

are slower at deciding what information was relevant
causing an increased P300 latency especially as the amount
of information needed to be remembered increased.
Pritchard [35] reports that several studies found that
P300 latency increased in a linear fashion with an
increase in memory load.
The decrease in memory functioning is suggestive of
lowered metabolic activity in both temporal and
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parahippocampal areas, thus we would expect to see a
negative correlation between the P300 latency and
metabolic activity of these areas.

As the P300 latency

increases, the metabolic activity observed in the
pareital, temporal and parahippocampal areas decreases,
important areas for the maintenance of an immediate memory
trace and consolidation to longer term memory.
There has been and continues to be controversy
regarding the neural generators of the P300.

Depth

electrode studies have suggested [1, 26, 37] that the P300
may be generated from the medial temporal lobe.

But these

studies have concluded that there are most likely multiple
generators rather than a unitary source.

It is probable

that several generators may contribute to a unitary
psychological function.

Many neural generators may need

to be activated to carry out a unitary psychological
process [12].

Although depth electrodes P3s and scalp-P3s

are not identical, Altafullah et al. suggests [1] that
there is enough resemblance to make hypotheses regarding
the generators.
In investigating the PET scans of Alzheimer's patients,
we are not able to trace the neural generators of the
P300, but rather to demonstrate the brain systems whose
integrity is necessary for the invoking of an early P300
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suggesting the ability of the brain to rapidly and
efficiently complete mental processing.
In summary, a decline in cortical metabolic activity
with the onset of Alzheimer's dementia, which initially
appears most markedly in the pareital area of the brain,
is a likely source of prolonged P300 latency found in DAT
patients. Thus, prolonged P300 latency appears to be a
sensitive index of diminished metabolic activity,
particularly in cortical association areas. Clinical
utility of P300 latency measures may thus lie not in its
ability to detect dementia in every case or to
differentiate dementias of different etiologies, but as a
relatively direct measure of the integrity of cortical
association areas.
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Table 1
Mans and Significance Levels
AGE

MMS

P3(Z)

P3(LAT)

--------------------------------------------------------

c

0.0

63.94

29.59 ab

0.0929 ab

334.7059 ab

0.5

65.89

25.00 c

3.1056

421.9445

1.0

68.43

22.71

·3.3800

436.7857

D
R

------------------------------------------------------a.

Control different from all PAD patients
(p < 0.0005)

b.

Control different from CDR 0.5, p < 0.0005.

c.

CDR 0.5 different from CDR 1.0, p < 0.0005.
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Figure Captions
Figure 1
Sample ERP traces from normal controls (CDR=O.O),
possible dementia (CDR=O.S) and probable dementia
(CDR=l.O).

Responses to the target and non-target tones

are superimposed with the area of the P300 wave elicited
by the target tone shaded.

Recordings are from midline

pareital (Pz), central (Cz) and frontal
referenced to an earlobe.

(Fz)

leads

Recording epoch is one second,

with tone onset at 100 msec.

Note that both PAD patients

show longer P3 latencies than those of normal controls.
For the traces illustrated in the right hand column
(CDR=l.O) there appears to be a clear P3a (orienting
response) and P3b (processing response) , the latter is the
wave of interest.

Figure 2
P3 latency data converted to Z-scores for all subjects.
From the left, columns are normal controls (CDR=O.O),
possible dementia (CDR=O.S), and probable dementia
(CDR=l.O).

The dashed line represents the maximum Z-score

value (1.8) for the normal controls of this study.

Only

five of the 35 patients fall within the range of normal
subjects.
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Figure 3
Correlation of P3 latency (in z-scores) with PET
measures.

From left to right, bars represent correlations

with the following PET measures:

global metabolic rate;

parietal metabolic rate divided by cerebellar metabolic
rate (Pt/Cb); temporal divided by cerebellar (Tmp/CB);
frontal divided by cerebellar (FT/Cb); parahippocampal
divided by cerebellar (PHp/Cb) ; caudate-thalamus divided
by cerebellum (Cth/Cb); and frontal divided by parietal
(Ft/Pt).

All correlations are positive when in the

predicted direction (all negative except for the last
column, Ft/Pt.

The dashed line represents the two-tailed

P< 0.5 level, adjusted for multiple comparisons.
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Figure 4
Correlation of P300 latency (in Z-scores) with PET
measures for patient and control group separated.
dashed bars represent the patient group.

The

The solid bars

represent the control group. From left to right bars
represent correlations with the following PET measures:
global metabolic rate for patient and control; parietal
metabolic rate divided by cerebellar metabolic rate
(Pt/Cb); temporal metabolic rate divided by cerebellar
(Tmp/Cb); frontal metabolic rate divided by cerebellar
(Ft/Cb); parahippocampal metabolic rate divided by
cerebellar (PHp/Cb) caudate-thalamus divided by cerebellum
(CTh/Cb); frontal metabolic rate divided by parietal
(Ft/Pt) and right perietal metabolic rate divided by left
parietal (R/L Pt) .

The dashed line represents the two-

tailed P< 0.5 level, adjusted for multiple comparisons.
The correlation of the frontal metabolic rate for the
patient group is the only PET measure that is significant
when the groups are separated.
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Alzheimer's Dementia:

The Relationship Between P300

Latency and PET Scan Ratios
The relationship between P300 latency and PET scan
measures of focal cortical and subcortical metabolic
activity was investigated in individuals considered to be
early cases of probable Alzheimer's type dementia (PAD).
The latency of the P300 component of auditory eventrelated EEG potentials (ERP) has been suggested to reflect
stimulus evaluation time, which increases significantly in
most cases of

neurological disease resulting in dementia.

The Positron Emission Tomography (PET) provides a
spatially discrete, quantitative, noninvasive measurements
of the rate of physiological activity of the living human
brain.
The PAD patient group consisted of individuals 56-76
years of age who scored below the normal range on the
neuropsychological battery and exhLbited behavioral
symptoms congruent with a diagnosis of mild dementia (MMS
20-27).

Non-Alzheimer types of dementia were ruled out by

extensive medical evaluation.

The control group consisted

of individuals 52-71 years of age who fell within the
normal range on a battery of neuropsychological tests (MMS
28-30).
An "auditory oddball" paradigm was utilized for P300
measurement,

(frequent tones 80%, target tones, 20%).

Each subject was instructed to count the target tone to
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her/himself.

P300 latencies were expressed in z-scores in

reference to the age/P300 regression line from a large
population of normal elderly to control for age
variations.
Each patient and control underwent a glucose
utilization PET scan using F-18 labeled 2-deoxy-2-flurorD-glucose (FOG) .

PET values from different brain areas

were reconstructed from multiple scans in the horizontal
plane.

Areas tested were expressed as ratios of

cerebellar metabolic rate, a relatively stable structure
in progressive degenerative dementia, to control for
individual differences.
A significant difference was found between PAD and
normal subjects in P300 latency, with those in the patient
group having longer P300 latencies than the control group
(p< 0.0005).

The P300 latencies were significantly

correlated with cortical, but not subcortical, metabolic
rates.

-

The highest correlation was between P300 latency

and parietal PET scores, with significant correlations
also for frontal, temporal and parahippocampal areas.
Results suggest that P300 latency is a sensitive measure
of the functional decline in cortical association areas
associated with early stages of Alzheimer's disease.
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Alzheimer's Disease, P300 Component of Event-Related
Potentials, and Positron Emission Tomography
in Diagnosis and Research in Aging.
With the increase of life expectancy within the last
century, we have had to confront new difficulties that
accompany older age.
termed Dementia,

One of these problems is one we have

a nonspecific clinical syndrome with an

organic etiology characterized by the deterioration in
intellectual, cognitive and psychological functioning.
The diagnosis of dementia is based on a cluster of
psychological as well as behavioral symptoms rather than
on a causative factor.

Often the specific causative

factor is not confirmed until post-mortem.
The criteria, according to DSM III, utilized to
diagnose dementia include:

(a)

loss of intellectual

ability resulting in social or occupational impairment;
(b) memory impairment;

(c)

impairment in abstract

thinking, judgment or higher cortical functioning or
personality change;

(d) retention of clear consciousness

and (3) documented or presumed evidence of a specific
organic cause.

Various disorders producing dementia
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include:

Alzheimer's disease, Pick's disease, Creutzfeld-

Jacob disease and Multi-infarct, as well as disorders in
which dementia is a significant, but not primary symptom~
Parkinson's and Huntington disease.

There are also

numerous metabolic and toxic states producing permanent or
reversible dementia.
Alzheimer's Type Dementia
Alzheimer's Disease was first diagnosed in 1907 by
Alois Alzheimer.

It is now the most common cause of

adult-onset dementia and is diagnosed in at least 50-55%
of all cases of dementia (Tomlinson, Blessed & Roth, 1970~
Kuhl, Metter, Reige & Hawkins, 1985).

Approximately 10-

15% (Price, Whitehouse, Struble, 1985) of persons over the
age of 65 years will become at least mildly demented with
50-60% of those suffering from Alzheimer's Disease.
Physicians describe at least two forms of Alzheimer's
(Lezak, 1983~ Barnes, 1987), one having an early onset
around the age of 50, and the other having an onset much
later.

Local or personal preference seems to dictate

whether dementia of the Alzheimer's type is considered a
presenile dementia (called Alzheimer's disease) or a
senile dementia (called senile dementia of the
Alzheimer's type).

Significant differences in rate of

cognitive decline have been found (Lezak, 1983~ Loring &
Larsen, 1985) between those patients with an early and
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those with a late onset of Alzheimer's dementia.

Those

who have an early onset of Alzheimer's dementia are found
(Loring & Larsen, 1985) to decline more rapidly and be
more impaired than those with a later onset.

Since

identical patholologic changes and clinical features are
found in both early and late onset dementia (Cummings and
Benson, 1983), this does not necessarily designate two
separate dementing diseases and thus this present
discussion will use the terminology Alzheimer's Disease
regardless of the age of the patient at onset.
Clinical Features
There are several observable clinical features that
accompany the onset of Alzheimer's Disease including loss
of memory, and disorders of language, praxis and
perception (Price et al., 1985), with the earliest signs
denoting Alzheimer's disease being a deficit in recent
memory, depression and irritability (Lezak, 1976).
Reisberg (1985) suggests seven phases in Alzheimer's with
the first three phases, which include forgetfulness and
early confusional states,
aging.

indistinguishable from normal

The onset of diagnosable PAD occurs at stage four

with deficit in areas of knowledge of current and recent
events, memory of personal history, concentration and
ability to travel, handle finances etc.
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McKhann, Drachman, Folstein, Katzman, Price, and
stadlan (1981) outline the criteria necessary for the
diagnosis of probable, possible and definite Alzheimer's
disease.

These criteria include: dementia established by

a clinical exam and documented by Mini-Mental Test, and
Blessed Dementia Scale; deficits in two or more areas of
cognition; no disturbance of consciousness; onset between
40 and 90 years of age.

A diagnosis of probable

Alzheimer's disease is made if there is a typical
insid~ous

onset of dementia that is progressive and no

other systemic or brain disease can account for the memory
and other cognitive deficits.
by:

This diagnosis is supported

impaired activities of daily living; family history

of similar disorders; and laboratory results such as CT
scan.

A diagnosis of possible Alzheimer's disease may be

made depending on the clinical course.

Definite

Alzheimer's Disease is not diagnosed until postinortem by
autopsy.
Cerebral Structure and Neurochemistry
Alzheimer's Disease is characterized by atrophy of the
cerebral cortex and dilation of cerebral ventricles.
"There is evidence that cognitive deficits in Alzheimer's,
especially memory, are related to a disorder of cortical
cholinergic innervation associated with selective
degeneration of cholinergic neurons whose cell bodies lie
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in the basal forebrain."

(Kuhl et al. 1985, p 419).

In

the past it was believed that patients with Alzheimer's
show a selective degeneration of cholinergic neurons
(Davis, 1979; Whitehouse, Price, Clark, Coyle, & Delong,
1982).
Chiro,

Foster, Chase, Mansi, Brooks, Fedio, Patronas, Di
(1984) brought this theory of selective

degeneration of acetylcholine-releasing neurons into
question, suggesting that this does not necessarily occur
throughout the cerebral hemispheres from forebrain nuclei
except in very the elderly.
In a study of 17 drug-free Alzheimer's patients and 15
normal subjects, Greenwald, Edasery, Mohs, Shah, Trigos
and Davis (1985) found no significant differences in red
blood cell choline, plasma choline or the ratio between
the two.

In a similar study Kanof, Greenwald, Mohs and

Davis (1985) compared choline uptake into the red blood
cells finding no difference in any kinetic parameters of
red cell choline uptake between the Alzheimer's patients
and controls.

They did find a strong correlation between

k

and V
values (calculated from Lineweaver-Burke plots
d
max
and expressed in units of nanomoles choline per gram

protein) for red blood cell choline uptake for the normal
groups but not the patients.

The authors suggest that

this may be due to a selective vulnerability of central

P300 and PET Research
45
cholinergic neurons in patients with Alzheimer's disease
resulting in an altered choline metabolism.
Price et al

(1985) state that reductions in presynaptic

markers for cholinergic neurotransmission are currently
the most consistent neurochemical observation in
Alzheimer's Disease.

Dysfunction and death to cells in

the areas of medial septum, diagonal band of Broca, and
basal forebrain cholinergic system may be partially
responsible for the reduction of cholinergic markers.
The difficulty in diagnosing dementia is that the
change in the cerebral anatomy is not necessarily
different than that of normal aging.

For some demented

patients, a CT scan shows no cerebral atrophy (Duara,
Grady, Haxby, Sundaram, Cutler, Heston, Moore, Schlageter,
Larson & Rapoport, 1986).
change.

Others may show little or no

Senile plaques and neurofibrillary tangles, which

are believed to be partially responsible for the dementing
process, are observable only at autopsy and are found in
both demented and non-demented persons, although usually
in different quantities in various regions. The
distribution of amyloid plaques and neurofibrillary
tangles in Alzheimer's appears to be more specific to the
hippocampus, amygdala and cerebral cortex regions of the
brain (Price et al, 1985< Barnes, 1987). However, this
overlapping with normal brain aging, along with the
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dependence upon behavioral signs for the clinical
diagnosis of dementia in the living patient, often causes
confusion between the various dementias, as well as
between dementia and various other conditions which have
similar behavioral features.

This is especially true with

elderly, depressed patients.
Recent studies (St George-Hyslop, Tanzi, Polinsky,
Haines, Nee, Watkins, Myers, Feldman, Pollen, Drachman,
Growdon, Bruni, Foncin, Salmon, Frommelt, Amaducci, Sorbi,
Piacentini, Stewart, Hobbs, Conneally & Gusella, 1987J
Tanzi, Gusella, Watkins, Bruni, St. George-Hyslop, Van
Keuren, Patterson, Pagan, Kurnit & Neve, 1987) have found
a familial and chromosomal pattern in Alzheimer's patients
suggestive of a genetic link.

This research suggests that

Alzheimer's, which has an early onset, may be caused by an
inherited abnormal gene which is located in the same
vicinity as chromosome 21.
(1987)

According to Tanzi et al.

the highest level of expression of the beta protein

gene was found in the association cortex, which may be
related to some of the clinical symptoms observed with
Alzheimer's.

They hypothesize that this protein might be

the basis of the inherited form of Alzheimer's.
addition research has shown

(Sj~gren,

Sj~gren,

In

& Lundgren,

1952) increased morbidity risk for family members of early
onset Alzheimer's patients.
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Changes in cerebral structure found in Down's Syndrome
are identical to that of Alzheimer's Disease (Crapper,
Dalton, Skopitz, Eng, Scott, Hachinski, 1975) which are
believed to be a consequence of the same chromosomal
defect as found in Down's patients.
presented on the chromosome 21

This defect is

(Reisberg, 1981).

Price,

Whitehouse, Struble, Coyle, Clark, DeLong, Cork and
Hedreen (1982) compared changes in the cholinergic system
of both persons with Alzheimer's Disease and older persons
with Down's syndrome and found support for a cholinergic
abnormality resulting from selective destruction of
neurons in the nucleus basalis of Meynert. They also found
a link between the selective lesion in the nucleus basalis
of Meynert and the cortical cholinergic deficiency which
may be responsible for the formation of neuritic plaques.
It has been stated (Reisberg, 1981) that 100% of person
with Down's syndrome who live into middle life will
develop a clinical and pathological condition identical to
Alzheimer's Disease.

The incidence of Down's syndrome is

higher in families of individuals with Alzheimer's
disease.
Neuropsychological Evaluation
Clinical neuropsychology presents one non-invasive
technique for the evaluation and diagnosis of dementia in
the elderly, as well as the differentiation from
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depression or other psychiatric, treatable conditions.
Albert (1984) categorizes mental functions into five basic
areas:

attention, language, memory, visuospatial ability

and conceptualization.

Numerous standardized test have

been developed for the assessment of these areas for both
impaired and non-impaired.

Research suggests (Lezak,

1983) that patient's with Alzheimer's Disease retain
functions that are familiar and overlearned longer (i.e.
scores on WAIS subtests Information, Vocabulary, many
Comprehension and Similarities items, and Digits Forward
are highest)

than unfamiliar, abstract, and speed-

dependent tasks (i.e. WAIS Block Design, Digit Symbol and
Digits Backward are often the lowest scores obtained).
Immediate span and short-term memory tend to be spared
(Lezak, 1983), whereas subtle language deficits can appear
very early in the disease.
Persons with delirium or clinical depression will
exhibit attentional deficits whereas individuals in the
early stages of a dementing disorder can often perform
simple attentional tasks within the normal range (Albert,
· 1984).

This area can be assessed by using Digit Span

forward, a simple and easily administered test of
attention.
Albert (1984) suggests that a comprehensive
aphasia examination be administered to assess the degree
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of impairment in comprehension, repetition, reading,
writing and naming abilities.

The Boston Naming Test

(Kaplan, Goodglass & Weintraub, 1978),

The Multiple

Choice Naming Test (Huff, Corkin & Growdon, 1983),

and

The Category Fluency Test have been utilized (Huff &
Corkin, 1984) to assess the presence of aphasia in
Alzheimer's patients.

While there do not appear to be

consistent deficits in naming ability with either
depression or delirium, persons with early Alzheimer's
Disease will show disturbances in naming.

They will often

make circumlocutory errors or errors of association.
Memory loss is characteristic of early Alzheimer's
Disease, but can also be seen in individuals with clinical
depression.

In contrast to the person with dementia, the

depressed person tends to recall as much or sometimes more
following a delay, whereas the demented patient will show
a dramatic loss of information following a delay.

Thus

memory assessment should include both immediate and
delayed memory tests according to Albert (1984).
Visuospatial skills can be assessed with a simple
copying task.

Deficits in visuospatial tasks will also be

seen with the Alzheimer's patient.

These patients will

show the decline in visuospatial skills seen with normal
aging such as slowing in ability to complete the tasks,
but may also demonstrate perseverative tendencies such as
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repeating an earlier drawing.

According to Albert (1984)

the "average mildly to moderately impaired Alzheimer
patient can generally perform simple visuospatial tasks
quite well"

(p. 316), but there is a subgroup whose

copying performance is grossly distorted and they often
complain of "not seeing right".

Albert stated that with

this subgroup, the perceptual abilities are almost always
more severely effected than their memory performance.
Proverb interpretation, Similarities, card sorting,
maze learning and list generation are tests suggested
(Albert, 1984) for the assessment of conceptualization.
The Alzheimer's patient will demonstrate significant
impairment in conceptualization of abstract information.
They tend to be much more concrete that those with normal
aging deficits.
Feher, Largen, Barr and Smith (1984)

found Alzheimer's

patients to fall significantly below the normal on a wide
range of neuropsychological tests including scores on the
WAIS Verbal, Performance and Full Scale IQ, Buschke
Selective Reminding Test, Dementia Rating Scale, Seashore
Rhythm Test, Digit Cancellation Test, Hidden Words Test
·~

and the Wechsler Memory Scale Visual Reproduction subtest.
Storandt, Botwinick, Danziger, Berg and Hughes (1984)
were able to correctly classify patients with mild
Alzheimer's Disease from normal, healthy older adults
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utilizing a battery of tests which included:

Wechsler

Memory Scale, Word Fluency Test, Boston Naming Test,
Entertainment Questionnaire, Visual Retention Test,
Wechsler Adult Intelligence Scale, Trailmaking A and a
Depression scale.

From this list of tests given they

found that with a short battery which included only WMS
subtests logical memory and mental control in addition to
Trailmaking A and Word Fluency 98% of the subjects were
correctly classified.
Pseudodementia
Depressive pseudodementia is the term often used for
patients who appear to have suffered a loss of cognitive
functioning, but who in reality are experiencing moderate
to severe depression.

This condition is reversible if

treated, and thus the importance of a correct differential
diagnoses is apparent.
dementia include:

Depressive symptoms which mimic

apathy, psychomotor retardation

impaired memory and judgment, orientation and intellectual
functions such as comprehension, calculation and general
knowledge.

Thus a common source of error in the diagnosis

of dementia is in those suffering from depression or
transient confusional states.

Wells (1979)

lists the

following distinctions between dement,ia and depressive
pseudodementia: in pseudodementia the person exhibits
short duration of symptoms, rapid progression of the
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difficulty, previous psychiatric dysfunctions, pervasive
affective changes, vociferous and detailed complaints of
cognitive impairment, "don't know" rather than the nearmiss answers, variability of performance, well-preserved
attention span and concentration.
There is controversy regarding the use of the
terminology, depressive pseudodementia.

Post (1975)

considers the category to be unimportant, stating that a
differential diagnosis can be made between depression and
dementia.

Shraberg (1978) regards the category to be

merely a myth.

Reifler, Larson and Hanley (1982) found

the concept to be of very little use.
The misdiagnosis of dementia, however, has serious
consequences.

The treatment of the patient may be

terminated upon the diagnosis of most types of dementia
since they are progressive and non-reversible.

The

patient may be placed in a nursing care facility and
negative attitudes within and toward the patient may
develop.

Families may withhold necessary emotional

support.
Thus, there is a need for more precise and objective
means of diagnosing dementia in the elderly.

The P300

component of auditory event-related potentials (ERP) has
shown promise for making a significant contribution to the
evaluation of cognitive functioning.
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P300 Component
The P300 (also referred to as P3) is the third
positive wave in the ERP which peaks at approximately 300
msec following the onset of a task-relevant, rare
stimulus.

The P300 is termed an "endogenous" component of

ERP's because it is reliant upon an internal evaluation
process of the stimulus by the subject.

Pritchard (1981)

suggests that the P300 is the actual phenomenon of
interest rather than being used merely as a measure for
drawing inferences regarding a different phenomenon of
interest.

Therefore the question to be asked is what

correlates with P300.

In fact there are many variables

which correlate with the presence or absence of P300 such
as:

stimulus probability; classification of stimuli

(signal or nonsignal); and task relevance.

Depending on

the instruction given to the subject, the stimulus will
serve in one of these various functions.
stimulus may or may not result in a P300.

Thus, the same
Based on this

differentiation, Pritchard suggests that the P300 is
"invoked" rather than "evoked".

The variations of the

experimental context result in an internal change as the
subject evaluates the stimulus.
Two conditions are required to elicit a P300 wave:
(a) a low probability stimulus, and (b) a discriminative
task given to the subject.

Typically an "auditory
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oddball" paradigm is used to elicit a P300.

Regularly

occurring auditory stimuli of a given pitch are
occasionally and randomly replaced with ones of a
different pitch and/or intensity. The infrequently
occurring stimuli are made task-relevant by having the
subject count them.

Averaged evoked EEG responses

elicited by the counted, infrequent stimulus manifest a
large positive wave (P300) which is not apparent in the
response to its frequent stimulus.

P300 disappears in the

response to rare stimuli if the subject ignores them.
Donchin (1981) states that P300 latency is not an
orienting response.
habituate.

He found that orienting responses

Once the stimulus is not longer novel, the

response does not occur.

P300 does not habituate, nor

does it disappear while the person is involved in the
stimulus task.

He suggests that the P300 is involved with

the process of memory modification or learning, and the
process manifested by P300 is association with the
updating of our schema.
P300 Amplitude
Past research (Pritchard, 1981) has demonstrated that
P300 amplitude and latency systematically correlate with a
number of specific cognitive manipulations.

Sutton,

Braren, Zubin and John (1965) were the first to

sugge~t

relationship between P300 amplitude and uncertainty

a
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resolution (information delivery) .

P300s were invoked

when the stimulus supplied the subject with information
(Pritchard, 1981).

But i t was soon discovered that

uncertainty resolution did not offer enough explanation of
the phenomenon of P300 amplitude.
In his review of the P300, Pritchard (1981)

found P300

amplitude to decrease as the subject's confidence in
his/her own perceptions decreased.

P300 amplitude

is larger following signals than nonsignals which
indicates the involvement of an interaction between
incoming information and memory.

Increased memory

capacity and functioning, which occurs with normal
development, is significantly correlated with
P300 amplitude.

Also, there is evidence that P300

amplitude invoked by task relevant stimuli is a function
of the actual use of the information by the subject.

As

subjects master a trail-and-error concept-formation task,
P300 amplitude decreases.

Furthermore, P300 amplitude

can, under some conditions, be predicted by the subject's
expectancy regarding signal presentation.

P300 amplitude

does appear to index perceptual limited-capacity
processing, meaning that when a P300 component is
observed, the subject was conscious of the stimulus that
preceded the component by roughly 300 msec. Polich (1986)
found in studying students with no neurological or
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psychological disorder that the amplitude of the P300
was affected by how conscientiously the subject is
involved in the task, i.e. attention.

P300 amplitude is

sensitive to perceptual load (Donchin, 1981).

If

perceptual demand for other concurrent tasks increases,
P300 amplitude in the original task decreases.
P300 Latency
Duncan-Johnson and Donchin (1979) and Duncan-Johnson
I

(1981) suggested that the P300 latency is a useful index
of the duration of stimulus-evaluation processes
independent of the time necessary for stimulus selection
and response execution.

Stimulus-evaluation processes are

defined as "the subset of cognitive operations involved in
the encoding, identification and categorization of a
stimulus"

(p. 209).

Duncan-Johnson and Donchin (1979)

recorded ERPs and response times (RT) from 12 male
subjects using a warned, choice RT task.

The subjects

were presented with a series of visual stimuli that fell
into one of three categories; match, mismatch or star.
The probability of the various stimuli appearing changed
over the course of the series.

Conditional probability

was found to be the principal determinant of P300 and RT.
The lower the probability, the later the P300 and the
slower and less accurate the response.

It was concluded

that P300 can be used as a measure of stimulus evaluation
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time in tasks with relatively low processing levels.
Duncan-Johnson (1981) concluded that P300 is not merely
another measure of response time,

like a motor reaction

time, but is in fact free from response-related factors.
This hypothesis has found support from many studies
(Squires, Donchin, Squires & Grossberg, 1977; Donchin,
Ritter & McCallum, 1978; Ford, Hink, Roth, Pfefferbaum, &
Kope 11 , 1 9 7 9) .
Picton, Stuss, Champagne and Nelson (1984)
no change in reaction time with age.

found

They suggest that

the P300 component is initiated in young adults at
approximately the same time as a motor response, although
the P300 compenent is independent of response time.

With

aging the P300 process occurs later than reaction time.
They suggest that there are two parallel processes
occurring in the brain, one generating the reaction time
the other a cognitive event which is manifested in the
P300 latency.
Fitzgerald and Picton (1983)

found that increasing the

difficulty for detecting target stimuli prolonged the
latency of the P300.

They conducted a series of three

experiments in which the target stimuli were varied in
degree of detection difficulty on 19 subjects ages 17 to
37 years.

The frequency of occurrence and number of target

stimuli were varied.

Subjects were instructed to count
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or press a button upon hearing the target stimulus.
Fitzgerald and Picton found that the P300 component was
significantly smaller in amplitude and prolonged in
latency for the more difficult target compared with the
easily detected stimulus.

This result occurred in all

three experimental conditions.

They postulated that the

amount and type of updating that occurs in the final
stage· of stimulus discrimination is indexed by the P300
component.
Hillyard, Squires, Bauer and Lindsay (1971) found the
P300 amplitude to increase as the confidence of the subject
regarding correct signal detection increased.

Paul and

Sutton (1972) were able to confirm this hypothesis
adding the relationship between the P300 compenent and
response bias to the confidence explanation.
Fourteen subjects ranging in age from 19 to 31 years
were studied by Brookhuis, Mulder, Mulder and Gloerich
(1983), using a visual task which increased in the amount
of information that needed to be remembered.

They found

that there was an overall main effect for the processing
load.

The P300 latencies were affected by the time needed

to make either a positive or negative decision but not by
response time.

P300 latencies increased as a function of

processing load or increased task difficulty.

Ford, Roth

and Kopell (1976) and McCarthy and Donchin (1981) also
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found support for the increase in P300 latency as task
difficulty increased.
Ford, Pfefferbaum, Tinklenberg and Kopell

(1982)

studied the P300s and response times of 10 elderly (mean
age 79 years) and 10 young (mean age 23 years) female
subjects each receiving a series of visual memory
retrieval tasks.

Subjects were instructed to press a

button with the index finger of one hand if the probe was
a positive and press the other button.with the index
finger of their other hand if the probe was negative.

The

Stimuli were numbers constructed with unconnected dots.
Some stimuli were degraded by adding random dots making
the identification more difficult.

They found that P300

latency was longer for the elderly subjects than for the
young as reported by others (i.e., Ford et al; 1979;
Pfefferbaum et al; 1980a).

The also found that increasing

the difficulty of the memory set from 2 to 4 prolonged the
P300 latency for the young subjects but not for the
elderly.
(1980).

This finding supports that of Pfefferbaum et al.
Ford et al. suggest that operations designed to

make the decisions more difficult (e.g, increasing memory
load) do not affect P300 latency but those designed to
make the discrimination more difficult (degrading) do
affect P300 latency.
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McCarthy and Donchin (1981) manipulated the stimulus
difficulty by visually presenting the word "right" or
"left" surrounded by either the # sign or other random
letters.

In addition the word "different" or "same"

appeared on the screen indicating which hand the subject
was to use in responding.

They found that the P300

latency was affected only the presence of noise (the words
surrounded by random letters) but not the incompatible
response instructions (different, meaning if the stimulus
word was "right" respond with your left hand).

McCarthy

and Donchin suggest that their data indicate that the P300
can serve as a dependent variable for studying human
information processing.
Polich (1986) studied 12 normal subjects between the
ages of 18 and 24 years using variations in frequency and
intensity of the target tone to determine the effect upon
P300 latency.

He found that P300 latency was not

significantly affected by variable of attention but was
stable, varying little as a function of the task when the
subject was engaged in a discrimination paradigm of some
type.

A decrease in P300 latency was found when subjects

were asked to ignore the stimuli.

Polich commented that

even when given instructions to ignore, there appeared a
P300 which he suggests may be an indication that some
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information processing occurs even when told to ignore the
stimulus.
P300 Generators
Much discussion has occurred regarding the location of
the neural generator(s) of the P300.

Depth electrode

implantation has offered general information of possible
areas where P300 generators may lie.

Altafullah, Halgren

Stapleton and Crandall (1986) studied responses from
electrodes implanted in the hippocampus, parahippocampal
gyrus and amygdala of 16 patients with partial complex
epilepsy in order to lateralize seizure activity.
found support for local generation of the P300.

They
Although

the Medial Temporal Lobe (MTL)-P3 is not identical to the
scalp-P3, they appear to be very similar.

They suggest

that MTL may generate a significant portion of the scalpP3 with the late posterior and lateral P300 reflecting
more MTL activity than the earlier fronto-midline P300 in
simple tasks.

They found that the scalp-P3 was about

twice as large as expected suggesting that the MTL is not
the sole source of activity resulting in a scalp-P3.

This

theory has found support by other investigators (Smith,
Stapleton & Halgren, 1986~ Halgren et\al, 1980, 1985a~
Squires et al, 1983 and Wood et al, 1984).

Smith,

Stapleton and Halgren (1986) found that MTL-P3 changes
during recognition memory tasks were small or absent to
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non-repeated words and large to word repetitions.

They

suggest that MTL-P3 might indicate the completion of MTL
involvement in memory search and retrieval operations.
According to Okada, Kaufman and Williams (1983), an
endogenous potential (200-630 msec) appears at the scalp
when a subject is involved in tasks requiring judgment
about a stimulus.

Intracranial recordings have found

increased single unit firing in or near the hippocampal
formation and amygdala while subjects were engaged in
task-relevant activities.

In their study of 3 young

adults using magnetic and electrical recordings, Okada et
al. suggest that their data strongly support the
hippocampal formation as the location of the major source
or sources of P300 for at least the right hemisphere.
These studies suggest the possibility of multiple
generators of the P300 component.

It has been discussed

in light of this indication (Fabiani, Gratton, Karis &
Donchin, in press) that multiple generators does not mean
multiple psychological processes are also involved.

Many

neural generators may be involved in order to activate and
carry out a unitary psychological process in diverse brain
regions.
P300 and Memory
Howard and Polich (1985) studied 24 children
(5-14 years) and 24 adults (20-40 years) using the Digit
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Span subtest of the Wechsler Adult Intelligence Scale
(WAIS) .

They found that as memory span increased, P300

latency decreased for the children relative to the adults.
They suggested that perhaps fewer resources are utilized
for encoding and item-identification processes when the
memory capacity is more developed, thus the shorter P300
latency.
Polich (1986) observed the ERPs of 100 undergraduates
(mean age 20.4 years).

He found P300 amplitude and

latency to be negatively correlated implying a systematic
relaiionship with the association the greatest at the
parietal/central scalp locations.

His data support

Donchin's {1981) theoretical interpretation of the P300 as
relating "incoming sensory information to memory updating
processes"

(Polich, 1986; p. 239) as well as

neuropsychological observations that the parietal lobe
engages in such activities.
M~ntysalo

and Gaillard {1986) studied ERPs of 9 normal

male subjects while completing a syllable learning task.
P300 latency was found to be longest for new syllables and
shortest during overlearning.

They suggest that the P300

invoked during the test phase when new syllables were
being introduced, could be associated with the updating of
working memory.

They indicate that this updating may

occur by a match/mismatch function, a prolonged cognitive
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process manifested in a long latency P300.

P300 amplitude

was found to be largest for learned items but smallest for
overlearned items during a word recall task.

These data

suggest that the evaluation of unlearned items takes
longer resulting in longer P300 latencies, than the
evaluation of just learned items which elicit larger P300
amplitudes.
Donchin (1981) proposes that the P300 is involved in
the process of memory modification or learning.

Responses

that are to be remembered may possibly be those processes
manifested by the P300.

He presented subjects with a

series of words displayed one at a time with half of the
words appearing dimmer on the screen.
told to memorize the dim words.

The subject was

The subject is then

tested with all words appearing at the same intensity.

He

found large differences between the ERPs elicited by the
words that were dim during the training phase, and those
that were bright during the training phase.

These

differences were not attributable to the intensity of the
words because all words were the same intensity during the
testing phase, rather the P300 differences are due to the
subject attempting to identify the words that were to be
remembered.
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P300 and Normal Aging
Changes have been found (Courchesne, 1977: Courchesne,
Ganz & Norcia, 1981) in the P300 that correlate with
cognitive development in children.

P300 latency decreases

from the ages of 5 to puberty, then stabilizes and then
increased with age.

Marsh and Thompson (1972) were

perhaps the first to report age differences in P300
latency measurements using auditory discriminative tasks.
An increase in latency was seen for normal elderly
individuals.

This was substantiated later by other

investigators (i.e, Brent, Smith, Michalewski &
Thompson, 1977: Ford, Roth, Johns, Hopkins & Kopell, 1979)
Pfefferbaurn, Ford, Roth & Kopell,

(1980a: 1980b) found

similar results with P300 and normal aging from data
collected from 8 elderly (74-90 years) and 12 young (20-29
years)

healthy, normal women.

The subjects were given

visual memory retrieval tasks and P300 recorded.

They

found that the elderly subjects differed significantly
from the younger subjects in three major areas:
amplitude at Pz was smaller for the elderly:

(a) P300

(b) P300

latency and response time were slower for the elderly
group: and tc)

the relationship between P300 and response

time was altered, less tightly coupled.

There was a

significant difference, not age related, in P300 latency
between the young and elderly groups, although there was
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no significant difference in P300 latency-reaction time
correlations.

These results were substantiated

(Pfefferbaum, Ford, Wenegrat, Roth & Kopell, 1984) with
a larger number of subjects and utilizing computerized
measures of P300 latency and single as well as averaged
trials.

In addition to the findings that P300 latency

increases with age, they also found that scalp topography
of the P300 changes with age.

P300s in young subjects

have a parietal distribution.

With age, the P300 becomes

more frontally distributed.
Goodin, Squires, Henderson and Starr (1978)

found that

P300 significantly increases with age in a linear fashion
at a rate of 1.2 msec per year.

Syndulko, Hansch, Cohen,

Pearce, Goldberg, Montan, Tourtellotte, and Potvin (1982)
found latencies to increase .7 at Fz, 1.0 at Cz and 1.1
msec per year at Pz.
and Kopell

(1984)

Pfefferbaum, Wenegrat, Ford, Roth,

found an increase of 1.0-1.5 msec per

year in P300 latency.

Brown, Marsh, and LaRue (1983)

further found that a exponentially accelerating curve
describ~d the P300 latency/age interaction more precisely

than merely a straight line.

They studied 49 normal

subjects (15-80 years) using a modified version of the
"auditory oddball" paradigm.

They suggested that the

slope for the regression line was different for persons
under 45 years of age than for those over 45 years.

They

P300 and PET Research
67

found that the P300/age correlation for subject under 45
years was not significant, whereas for those over 45 years
of age, the P300/age correlation was highly significant
and yielded a linear slope of 3.14 msec/year.

They

suggest that P300 latency is a positively accelerating
function of age.
Picton, Stuss, Champagne and Nelson (1984)

found no

evidence of a curvilinearity in the regression line of
P300 latency for normal aging in their study of 72
subjects ages 20-79 years.

They suggest that in addition

to the linear age effect on P300 latency there may also be
other variables related to subject selection which affects
P300 latency and may bring out a curvilinearity in the age
regression.
P300 and Dementia
The latency of the P300 increases beyond the effects
of age, in most cases, for persons with a neurological
disease which results in dementia, whereas persons with
functional disorders or neurological disease without
cognitive impairment rarely exhibit an increase in P300
latencies (Goodin et al. 1978; Squires, Chippendale,
Wrege, Goodin, & Starr, 1980; Brown, Marsh & LaRue, 1982).
Brown, March and LaRue (1982) studied 24 elderly (50-81
years) normal subjects and an inpatient group of 25
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individuals (65-88 years) who had been admitted to the
hospital for treatment.

The patient group consisted of

individuals diagnosed with Alzheimer's Disease (10),
multi-infarct (5),

dementia associated with Parkinson's

Disease (3), and depression with no dementia (7).
Utilizing the P300 latencies from an auditory oddball
paradigm, to diagnose the subjects, they found that no
psychiatric cases were classified as demented (i.e. these
did not fall outside 2 SD of the age/P300 regression
line) .

Whereas three non-demented patients were

classified as demented with the MMS, there were no false
positives using P300 latency.

False negative (failing to

detect the presence of dementia) occurred in 7 of 17
patients using the P300 latency.

It was suggested that

the P300 and the MMS could be used in conjunction for the
most accurate differential diagnosis of patients as
demented or non-demented (i.e. depressed).
Syndulko et al.
Goodin et al.

(1982)

replicated the findings of

(1978) focusing more specifically upon

elderly patients with the diagnosis of moderate
progressive dementia.

Their findings suggest that not

only is the P300 latency useful to discriminate functional
from any dementing disorder, but specifically from primary
dementing disorders.
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In contrast to these studies, Pfefferbaum, Wenegrat,
Ford, Roth and Kopell (1984b) concluded that the P300
latency is not sensitive enough for clinical diagnoses.
They studied three inpatient groups, one consisted of
patients who demonstrated clinical evidence of cognitive
impairment and two groups who met criteria

for

schizophrenia and major depression (Research Diagnostic
Criteria, Spitzer & Endicott, 1978).

They found that

although there were differences in P300 latency and
amplitude in the three groups, they were not large enough
nor specific enough for clinical differentiation.

The

demented group had significantly prolonged P300 latencies,
but less than 50% fell 2 SD outside the predicted age
related score.

Twenty to thirty percent of the

schizophrenic patients had P3 latencies more than 2 SD
longer than the mean for their age.
Lai (1984) suggested that these conclusions may be a
result of the fact that the schizophrenic subjects were
chronic patients medicated on neuroleptics.

It is quite

likely that some of these patients were also in fact
organically impaired.
P3a
A moderate number of false negative diagnoses for
dementia using P300 may be accounted for by the
confounding occurrence

of "P3a".

Squires, Squires, &
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Hillyard,

(1975) differentiated an early P300 wave (P3a)

from a later occurring P300 wave (P3b) .

The P3a peaked

between 220-280 msec in young normals and had a frontal
scalp distribution when these subjects were asked to
ignore the stimuli.

When asked to count the rare stimuli,

the P3b occurred at 310-380 msec with a parietal scalp
distribution.

P3a was not found in all cases of active

attention, while at other times it could be seen
superimposed upon a P3b component.

Thus, P3a appears to

occur in both active and passive conditions, although it
may be obscured in the active condition by the P3b.

P3a

may be an index of a basic sensory mechanism which
registers any change in background stimulus and thus can
be interpreted as an orienting response.
al,

Ford, Roth et

(1976) confirmed the existence of P3a.
In the case of patient testing, it is likely that a

P3a would occur without a P3b in those persons who are
unable to understand or retain the instructional set.
However, failure to recognized the wave as P3a may lead to
the conclusion that the P300 (P3b) was within normal
limits, and that the person was not demented.

Thus it may

be that the early P300 wave found in some clearly demented
patients was in fact a P3a.

Thus measurement of P3a

rather than P3b would result in false negatives for
dementia.
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Lai et al.

(1985) have demonstrated that the P3a

confounded the measurement of P300 (P3b) , and subsequent
diagnosis, in two ways;

(a) in some cases P3a preceded P3b

as an inflection of a fairly distinct wave or (b) P3a was
the only P300 wave elicited to the infrequent stimulus.
This often occurred in severely demented patient.
al.

Lai et

(1985) added a third surprising tone which was non-

task-relevant to the typical "auditory oddball" paradigm
in order to elicit P3a in isolation.

Also the stimulus

differentiation was made more difficult by eliminating the
intensity differences between target and frequent tones.
This was thought to increase P3b latencies in elderly
patients.

Thus P3a and P3b would be more distant.

Lai et al.

(1985) found the expected

decreasing

amplitude from posterior to anterior for P3b, and an
increasing amplitude from posterior to anterior with the
P3a.

P3b was found to be significantly different in

latency between the normal and patient groups, but P3a
measurements were not different.

For patients with Mini-

Mental State scores greater than 26 and less than or equal
to 26, P3b was again significantly different while P3a was
not.
Contrary to earlier suggestive evidence (Brown et al,
1982), Lai et al,

(1985)

found that P300 latency did not

appear to discriminate Primary Degenerative Dementia from
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Multi-infarct or Parkinson Dementia.

Polich

et al.

(1986) also found no statistical difference between
different diagnoses of dementia and P300 latencies.

It

appears from these studies that at least for group
averages the dementing illnesses produce similar effects
on P300 latency and amplitude across etiologies.

The many

factors which contribute to a variety of dementing
illnesses apparently have some relatively common factor
which serves to increase the P300 latency independent of
age related changes. Thus P300 latency measurements may
prove to be an important tool in the differential
diagnosis between demented and non-demented patients, but
thus far does not provide information regarding various
possible etiologies of dementia.
One possible cause for the occurrence of a P300
outside the normal range for some demented persons and not
for others could be the sensitivity of the P300 latency to
cortical integrity within specific brain regions or
systems.

That is, regardless of the global level of

dementia, certain specific neural tissue must be
dysfunctional for P300 latency to become abnormally long.
Thus, different an~tomical progressions or different
stages of various dementing processes may or may not
impinge on neural systems influencing P300 latency.
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Positron Emission Tomography
With the new advances of the Positron Emission
Tomography (PET), it is now possible to measure the
metabolic activity of specific brain regions in living,
active patients.

The earliest and most specific changes

occurring in various diseases of the brain are reflected
in disturbances of underlying biochemical processes and
thus are apt to be detectable by PET scanning.
Three major components are required in order to
obtain quantitative ratios of biochemical activity using
the PET scanner:

injectable compounds labeled with

radioisotopes, the positron tomograph, and tracer kinetic
mathematical models.
Radionuclides such as Fluorine-18 can be used to
label biological substrates or analogues such as glucose
or water and then be injected into the blood stream of the
subject. This short-lived radioisotope then circulates and
otherwise interacts in a normal physiological manner.

In

the case of Fluorine-18 labeled glucose the radioisotope
is thus taken up into active neural tissue.

The greater

the activity level of specific tissue, the greater the
uptake of the radioisotope.

The isotope Flurodeoxyglucose

is a very unstable form of fluorine with as half-life of
approximately 17 minutes.

It is quickly transported to·

the brain since glucose is the only source of energy
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utilized by the brain.

Trapped with active neural cells,

the unstable isotope releases an unequal number of
electrons and protons resulting in collisions which form
the very energetic gamma rays.
The tomograph is an array of radiation detectors
placed circumferentially around the head of the patient.
These detectors record the emission of gamma rays from
the tissue distribution of positron activity within neural
tissue which has taken on the radioisotope by normal
physiological activity.

The data collected are then

processed by a computer to form a tomographic brain image.
Images can be constructed for multiple 2-dimensional
planes, comprising in all a 3-dimensional image of brain
physiological activity.

Thus PET provides a spatially

discrete, quantitative, noninvasive measurements of the
rate of physiological activity of the living human brain
in three-dimensional perspective.
Tracer kinetic models represent mathematical
descriptions of biochemical reaction sequences.

Each

segment of the sequence is a compartment, and differential
equations describe the movement of the natural labeled
compounds between the compartments.

Measurements are made

of the flux between compartments which are then used to
determine the rate at which the reaction sequence
proceeds.

These reaction rate calculations form the

P300 and PET Research
75
numerical basis of the digital brain image created by
positron emission tomography.
Due to the short half-lives of the positron-emitting
isotopes, it is possible to perform multiple studies in a
single setting to observe the effects of changes in
spontaneous or stimulus-induced alterations on regional
brain' distributions of different biochemical processes.
PET and Normal Aging
The study of cerebral blood flow (CBF) and cerebral
metabolism in normal aging as well as dementia has yielded
contradictory results.

Some researchers (Kety, 1956;

Navitomi, Meyer, Sakai, Yamaguchi, & Shaw, 1979) suggest
that CBF and cerebral metabolism decrease with age.
Others (Butler, Dastar, & Perlin, 1965; Fujishima, & Omae,
1980) report no change.

De Leon and his associates (De

Leon, Ferris, George, Christman, Fowler, Gentes, Reisberg,
Gee, Emmerich, Yonekura, Brodie, Kricheff and Wolf, 1983)
studied PET scans of 15 young normal subjects (mean age
26.1), 22 elderly normal subjects (mean age 66.6), and 24
mild to severe Alzheimer's patients (mean age 73.4).
Their results failed to demonstrated any significant
difference in glucose metabolism due to normal aging
although there was a trend toward decreased metabolism
within the older normal group.

P300 and PET Research
76

PET and Dementia
All diseases of the brain result from'or produce focal
or diffuse biochemical changes, reflective of functional
brain disturbance. PET images display functional
processes, often

demonstrating

larger, earlier and more

distributed lesions than those found in anatomically
oriented techniques (CT or MRI scans) .

Significant

correlations exist between the PET measures of glucose use
and the measures of cognitive functioning in demented
patients (de Leon et al. 1983).

The cognitive deficits of

Alzheimer patients may have focal as well as a generalized
decrease in cerebral glucose metabolism (Foster, Chase,
Fedio, Nicholas, Patronas, Brooks, & Di Chiro, 1983).
The PET scan has been found to be more consistently
related to cognitive decline than the CT scan (de Leon,
George, Ferris, Rosenbloom, Christman, Gentes, Reisberg,
Kricheff & Wolf, 1983).

In their study of 19 subjects

(60-85), with 8 Alzheimer's patients and 11 normal
subjects, de Leon et al.

(1983) found all mean regional

glucose use values to be significantly lower for the
Alzheimer's patients.

However, no differences were found

with the regional CT scan data between the two groups.
Interestingly though, they found a correlation between
structural attenuation and mental status in the region of
the temporal lobes for the CT scan.

There was also a
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correlation between thalamic CT attenuation and global
reduction in brain metabolic activity.

They suggest that

the anatomic and metabolic changes may reflect impairment
of thalamic functions although this is speculative at this
point.

Similar results were found by Duara, Grady, Haxby,

Sundaram, Cutler, Heston, Moore, Schlageter, Larson and
Rapoport (1986).

They found no atrophy with the CT scan

but reduced cerebral metabolism for 21 patients with a
clinical diagnosis of Alzheimer's Disease.
De Leon et al.

(1983) found that they were able to

correctly classify the Alzheimer's patients with accuracy
greater that 80% utilizing the reduced glucose metabolic
rate noted for the PET scan.

They found consistent

correlations between measures of glucose utilization and
degree of cognitive impairment.
Kuhl, Metter, Riege and Hawkins (1985) found that 2deoxy-2-fluror-D-glucose (FDG) scan is a sensitive
indicator of local brain dysfunction in Multi-infarct
dementia (MID).

In MID, multiple lesions from focal

ischemia caused an abnormal cerebral metabolic pattern.
FDG scans revealed scattered metabolic defects in cortex,
caudate, thalamus, white matter and cerebellum.
Patients with Huntington's disease were found (Kuhl et
al, 1985) to have markedly depressed glucose utilization
(20%) in the.caudate and putamen regardless of duration of
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the disease or the presence or absence of caudate atrophy.
They suggest that decreased metabolism appears to be a
"process that occurs prior to bulk loss of striatal
tissue"

(p. 421).

In Alzheimer's type dementia, the FDG PET scan
revealed (Kuhl et al., 1985) abnormal metabolic patterns
which reflected neuronal degeneration most severe in the
cortex.

The average decrease in zonal metabolism was 47%

in parietal and dorsolateral occipital cortex, and 28% in
caudate and thalamus.
(1985)

Friedland, Budinger, Koss and Ober

found a glucose metabolic decrease of 27% in the

temporal-parietal cortex of an Alzheimer group.

Chase,

Fedio, Foster, Brooks, Di Chiro and Mansi (1984) found a
significant positive correlation between cortical glucose
use measured by the PET and the Full Scale IQ, Verbal IQ
and Performance IQ scores on the Wechsler Adult
Intelligence Scale in both normal and demented patients.
The VIQ correlated more closely with cortical metabolism
in the left cerebral hemisphere while PIQ correlated with
cerebral metabolism of the right hemisphere.
Greater impairment in cortical glucose metabolism was
found in another study (Koss, Friedland, Ober & Jagust,
1985) specifically for the right hemisphere in patients
with early Alzheimer's disease. They studied 18 patients
who met the DSM-III criteria for primary degenerative
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dementia finding that the decline in metabolism was
related to age of disease onset.

Thus they suggest once

again that Alzheimer's Dementia has two distinct
populations.

From their research they define a unique

subset of patients under 65 years with a decrease in right
hemisphere metabolic activity.
Foster, Chase, Mansi, Brooks, Fedio, Patronas and Di
Chiro (1984) found a 10-49% decrease in glucose
utilization within the Alzheimer's group when compared
with the control group.

They observed that the posterior

parieto-temporal areas were the most affected, whereas the
frontal cortex and sensorimotor cortex were least
affected.

They postulated that as the disease progressed

the frontal lobe would also become subject to
deterioration.

These finding support those of Friedland,

Budinger, Ganz, Yano, Mathis, Koss, Ober, Heusmann and
Derenzo (1983) who also found cortical degeneration to be
most marked in the posterior temporal and parietal regions
in Alzheimer's patients.
Frackowiak, Pozzilli, Legg, DuBoulay, Marshall, Lenzi
and Jones (1981) found a decline in cerebral blood
flow and cerebral oxygen utilization which was correlated
with severity of dementia.

They found the parietal area

to be most affected with a 29-33% fall in cerebral blood
flow.

There was a similar decline in the temporal area
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also.

Bilateral metabolism decrease was found (Friedland,

Budinger, Brant-Zawadzki & Jagust, 1984) in temporalparietal cortex, and more markedly in the right
hemisphere in their study of two Alzheimer's patients.
PET, P300 and Dementia
Given the new technological advances of the PET scan
and the P300 latency measures, this study will investigate
the relationship between these two techniques in
individuals considered to be early, mild cases of
Alzheimer's type dementia.

Based upon past research, the

use of both P300 latency and PET scan measures could
assist greatly in the diagnosis of Alzheimer's Disease,
perhaps even in its very early stages.

One would expect

to find decrease metabolism in the parietal, temporal and
parahippocampal areas as well as a prolonged P300 latency.
In combination, these two methods could greatly reduce the
incidence of misdiagnosis.

Furthermore in studying the

relationship between the PET Scan and P300 latency,

more

understanding of the possible neural systems influencing
the P300 may be gained.

It is possible that the integrity

of the parietal, temporal and parahippocampal systems is
necessary in order to invoke a age-normal P300 latency.
Thus as these system begin to decrease in their rate of
glucose metabolism, the processes necessary for a normal
P300 become less efficient.

Perhaps fewer resources are
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available for the encoding and processing of information,
resulting in a prolonged P300 latency.

Thus, a better

understanding of the relationship between P300 and PET may
enlighten us regarding the false negative that occur with
the use of the P300 in diagnosis dementia.

It is possible

that, as long as the parietal and temporal systems are
fairly well intact, the stimulus evaluation time is not
decreased and normal P300 latency is seen even though the
person may have signs of a dementing illness.
hypothesized that:

(a)

Thus, it is

the P300 latency is a reflection

of brain integrity which will be manifest in PET indices
of metabolic rate.

(b) P300 latency will reflect cortical

versus subcortical metabolic rate.

(c) P300 latency will

be specifically longer in those patients with reduced
parietal and/or temporal metabolic rate.
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Table 2
Correlations of PET and P300 Latency Measures for PAD
Group Only
P300 Z-score

P300 Raw Score

-----------------------------------------------------0.2093

Global

-0.2194

p
Parietal/
Cerebellum

=

=

=

0.450

-0.1237
p

Right Par/
Left Par

=

0.250

=

0.128

=

p

0.098

-0.2271

=

p

0.106

-0.3771

*

p

=

0.017

-0.0518
p

=

0.389

-0.1913
p

0.2071
p

0.165

-0.2350

0.154

0.008

=

p

0.072

-0.0230
p

Frontal/
Parietal

0.078

-0.4193
p

CaudThal/
Cerebellum

=

0.114

-0.1778

-0.1863
p

Frontal/
Cerebellum

=

=

p

-0.2640
p

Parahip/
Cerebellum

0.125

-0.2569
p

Temporal/
Cerebellum

=

=

0.147

0.2077
p

=

0.127

*

p < 0.0012
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Table 3
Correlations of PET and P300 Latency Measures for Control
Group Only

Global

P300 Z-score

P300 Raw Score

-0.3762

-0.4844

p
Parietal/
Cerebellum

Temporal/
Cerebellum

p

=

0.378

Parahip/
Cerebellum

=

0.066

p

Frontal/
Cerebellum

=

0.180

p

CaudThal/
Cerebellum

=

0.421

p

Frontal/
Parietal

=

0.184

p

Right Par/
Left Par

=

0.117

p

=

0.101

0.110

=

0.132

=

0.234

=

0.258

0.2792
p

=

0.139

0.3849

0.3257
p

=

0.1693

0.3055
p

0.388

0.1885

0.2330
p

=

0.2874

0.0526
p

0.024

0.3144

0.2366
p

=

0.0748

0.3797
p

p < 0.0012

0.068

-0.0811
p

*

=

p

=

0.064
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Table 4
Corr~lations

for PET and P300 Latency Measures for PAD and

Control Groups Combined
P300 Z-score

P300 Raw Score

-----------------------------------------------------0.2112
-0.2232

Global

p
Parietal/
Cerebellum

=

0.001

=

0.003

Frontal/
Cerebellum

CaudThal/
Cerebellum

=

0.001

*

p = 0.003

*

p = 0.002

*

p = 0.001

0.2500

0.2219

Right Par/
Left Par

0.2604
p

=

0.035

*

-0.4330

p = 0.405

0.042

*

-0.4068

p = 0.479

=

*

-0.3946

-0.0351

p

p < 0.0012

p

-0.0078

Frontal/
Parietal

*

*

-0.4662
p = 0.001

0.062

-0.4962

-0.3803
p = 0.004

=

p

-0.3915
p

Parahip/
Cerebellum

0.073

-0.5336
p

Temporal/
Cerebellum

=

p

=

0.063

0.2623
p = ',0.034
'

*
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Figure Captions
Figure 5:
This scatterplot displays the regression line
for the correlation of P300 Z-scores and the
parietal/cerebellum ratio.
data point.

"A" represents each patient

"C" represents each control data point.

Figure 6:
This scatterplot shows the correlation of the P300
scores and the temporal/cerebellum correlation.
indicates patient.

z-

"A"

"C" indicates control.

Figure 7:
This figure displays the P300 z-score and
frontal/cerebellum ratio correlation and regression line.
"A" represents the patient, and "C" represents the
control.
Figure 8:
This scatterplot shows the correlation between P300 zscores and the parahippocampus/cerebellum ratio.

The "A"

indicates a patient data point, the "C" a control.
Figure 9:
This figure shows the P300 z-score and global measure
correlation and regression line.
data point, "C" a control.

"A" indicates a patient
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Figure 10:
This shows the correlation for P300 z-scores and the
frontal/parietal ratio.

Patients are indicated by "A",

controls by "C".
Figure 11:
The scatterplot shows the P300 z-score and right/left
parietal ratio correlation with patients desinatedby "A"
and controls by "C".
Figure 12:
Thei figure shows the correlation between the P300 zscores and the caudate thalamus/cerebellum ratio.
Patients are repsented with an "A", controls with a "C".
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Descr1pt1ve stat1st1cs
CODE OR
OBS. RANGE

VARIABLE

GROUP
DEt-ENT
NORMAL
51AGE
290P300LAT
P3SD
-1.66SEVERITY
CDRO
CDRS
CDRl
MMS
20Total N = 49

1
2
76
575
8.22
0
5
1
30

N (%) OR
t-EAN

STAND. DEVIATION
SAMPLE/POP. EST.

49 ( 100%)
32 (65.3)
17 (34.7)
6.457
65.939
6.524
395.918 67.949 68.653
2.139
2.335
2.359
49 (100%)
17 (34.7)
18 (36. 7)
14 (28.6)
25.939
3.067
3.098

Correlation Coeff1c1ents
Var1 abl es
2.
3.
4.
6.
2. AGE
1.00
• 21 1.00
3. P300LAT
4. P3SD
-.03 • 95 1.00
6. MMS
-.31 -.65 -.59 1.00
N

= 49
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All Subjects by Diagnosis
ANALYSIS OF VARIANCE
SUMMARY TABLE FOR AGE
PALLAIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO
p

VARIABLE
GROUP

R

=

.23

.OS

1
df2

Notes:

2.52

.1

= 47

N = 49

AGE MEANS
GROUP

MEAN

N

DEMENT
NORMAL

67.0000

32

63.9412

17

AGE Mean

= 65.9

Standard deviation

= 6.5
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All Subjects by CDR
ANALYSIS OF VARIANCE
SUMMARY TABLE FOR AGE

VARIABLE

PALLAIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO

p

--------------------------------------------SEVERITY R = .28

.08

2

1.88

.2

df2 = 46
Notes: N = 49
Effect size 1s multiple correlation/eta (R).
AGE
SEVERITY
CDRO
CDRS
CDR1
AGE Mean

= 65.9

MEANS
MEAN
63.9412
65.8889
68.4286

N

17
18
14

Standard deviation

= 6.5
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All Subjects
F TEST OF CORRELATION
SUMMARY TABLE FOR AGE

VARIABLE
MMS

PALL AIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO
r = -.31

.10

5.01

1

df2

p
.03

= 47

Notes: N = 49
Effect size is product-moment correlation (r).
Tests are two-tailed. For a one-ta1led test, divide
the p of any variable w1th df = 1 by two IF the results
are in the predicted d1rect1on.
ESTIMATING SCORES FOR AGE FROM MMS
Samples of
MMS
20.0
23.0
25.0
28.0
30.0

Estimated
AGE
69.820
67.860
66.552
64.592
63.284

SE of estimate = 6.1378
Linear equation= 82.89203 + (-.65359 )
AGE Mean = 65.9

*

MMS

Standard deviation = 6.5
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All Subjects by CDR
ANALYSIS OF VARIANCE
SUMMARY TABLE FOR P3SD
PALLAIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO

VARIABLE

p

--------------------------------------------SEVERITY R = .64

.41

2

15.98 <.0005

df2 = 46
Notes: N = 49
Effect size 1s multiple correlation/eta (R).
P3SD MEANS
SEVERITY

MEAN

N

----------------------17
.0929
CDRO
CDRS
CDR1
P3SD Mean

= 2.1

3.1056
3.3800

18
14

Standard deviation = 2.3
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All Subjects by CDR
ANALYSIS OF VARIANCE
SUMMARY TABLE FOR P300LAT

VARIABLE

PALLAIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO

SEVERITY R = .66

.44

2

p

17.98 <.0005

df2 = 46
Notes: N = 49
Effect size is multiple correlation/eta (R).
P300LAT MEANS
SEVERITY

MEAN

N

----------------------17
334.7059
CDRO
CDRS
CDR1
P300LAT Mean= 395.9

421.9445
436.7857

18
14

Standard deviation = 67.9
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All Subjects by CDR
ANALYSIS OF VARIANCE
SUMMARY TABLE FOR MMS

VARIABLE

PALL AIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO

p

--------------------------------------------SEVERITY R = .92

.84

2

122.24 <.0005

df2 = 46
Notes: N = 49
Effect size is multiple correlation/eta (R).
MMS
SEVERITY
CDRO
CDR5
CDR1
MMS Mean

= 25.9

MEANS
MEAN
29.5882
25.0000
22.7143

N

17
18
14

Standard deviation

= 3.1
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All Subjects by P300 Z-Score
F TEST OF CORRELATION
SUMMARY TABLE FOR f.f.1S

VARIABLE

PALL AIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO

p

--------------------------------------------r = -.59

P3SD

.35

1

df2

25.25

<.0005

= 47

Notes: N = 49
Effect size is product-moment correlation (r).
Tests are two-tailed. For a one-tailed test, divide
the p of any variable with df = 1 by two IF the results
are 1n the predicted direction.
ESTIMATING SCORES FOR MMS FROM P3SD
Samples of
P3SD
-2.0

Estimated
MMS
29.152
27.599
26.047
23.718
22.165

.o

2.0
5.0
7.0
SE of estimate

= 2.4734

linear equation= 27.59919 + (-.77634 )
MMS Mean

= 25.9

* P3SD

Standard deviation = 3.1
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All Subjects by P300 Raw Latency Score
F TEST OF CORRELATION
SUMMARY TABLE FOR MMS

VARIABLE

PALLAIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO

p

--------------------------------------------P300LAT

r = -.65

.42

1

33.77

<.0005

df2 = 47
Notesz N = 49
Effect size is product-moment correlation (r).
Tests are two-tailed. For a one-tailed test, divide
the p of any variable with df = 1 by two IF the results
are in the predicted direction.
ESTIMATING SCORES FOR

M~S

FROM P300LAT

Samples of
Estimated
P300LAT
Mt~S
290.0
351.0
411.0
472.0
532.0

29.030
27.250
25.499
23.718
21.967

SE of estimate = 2.3393
Linear equation= 37.49298 + (-2.9180000E-02 )
MMS Mean

= 25.9

* P300LAT

Standard deviation = 3.1
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CDR 0.0 versus CDR 0.5
ANALYSIS OF VARIANCE
SUMMARY TABLE FOR P3SD

VARIABLE

PALLAIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO

p

--------------------------------------------SEVERITY R = .70

.48

1

30.90

<.0005

df2 = 33
Notes: N = 35
Effect size is multiple correlation/eta (R).
Tests are two-tailed. For a one-tailed test, divide the p
of any variable with df = 1 by two IF the results are 1n
the predicted direction.
P3SD MEANS
SEVERITY
CDRO
CDRS
P3SD Mean = 1.6

MEAN
.0929
3.1056

N

17
18

Standard deviation = 2.2
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CDR 0.0 versus CDR 0.5
ANALYSIS OF VARIANCE
SUMMARY TABLE FOR P300LAT

VARIABLE

PALLAIEFFECT BARTLETT CHI SO. OR
SIZE
V
DF1 F RATIO
p

--------------------------------------------SEVERITY R = .71

.50

1

df2

33.66

<.0005

= 33

Notes: N = 35
Effect size is multiple correlation/eta (R).
Tests are two-tailed. For a one-tailed test, divide the p
of any variable with df = 1 by two IF the results are in
the predicted direction.
P300LAT MEANS
SEVERITY

MEAN

N

----------------------CDRO
334.7059
17
CDRS

P300LAT Mean

= 379.6

421.9445

18

Standard deviation

= 61.4

i

I,,
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CDR 0.0 versus CDR 0.5
ANALYSIS OF VARIANCE
SUMMARY TABLE FOR MMS

VARIABLE

PALLAIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DFl F RATIO

p

-----------------~---------------------------

SEVERITY R = .89

1

.80

df2

131.70 <.0005

= 33

Notes: N = 35
Effect size is multiple correlation/eta (R).
Tests are two-tailed. For a one-tailed test, divide the p
of any variable with df = 1 by two IF the results are in
the predicted direction.
MMS
SEVERITY

~ANS

MEAN

N

----------------------CDRO
29.5882
17
CDRS
MMS Mean = 27.2

25.0000

18

Standard deviation = 2.6

,
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PAD Subjects by CDR
ANALYSIS OF VARIANCE
SUMMARY TABLE FOR P3SD

VARIABLE

PALLAIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO

p

--------------------------------------------SEVERITY R = .06

.00

.12

1

df2

n. s.

= 30

Notes: N = 32
Effect size is multiple correlation/eta (R).
Tests are two-tailed. For a one-tailed test,
divide the p of any variable with df = 1 by two IF the
results are in the predicted direction.
P3SD MEANS
SEVERITY
CDRS
CDR1
P3SD Mean

MEAN
3.1056
3.3800

N

18

14

= 3.2 Standard dev1at1on = 2.1
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PAD Subjects by CDR
ANALYSIS OF VARIANCE
SUMMARY TABLE FOR P300LAT

VARIABLE

PALL AIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO

SEVERITY R = .12

.01

.44

1

df2

=

p
n.s.

30

Notes: N = 32
Effect s1ze 1s multiple correlation/eta (R).
Tests are two-tailed. For a one-tailed test, d1v1de
the p of any variable with df = 1 by two IF the results
are in the predicted direction.
P300LAT MEANS
SEVERITY
CDRS
CDR1
P300LAT Mean

= 428.4

MEAN
421.9444
436.7857

N

18
14

Standard deviation

= 61.3
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PAD Subjects By MMS
F TEST OF CORRELATION
SUMMARY TABLE FOR AGE
PALLAIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO

VARIABLE

p

--------------------------------------------MMS

r

= -.31

.10

3.25

1

df2

.08

= 30

Notes: N = 32
Effect size is product-moment correlation (r).
Tests are two-tailed. For a one-ta1led test, divide
the p of any variable with df = 1 by two IF the results
are 1n the predicted direction.
ESTIMATING SCORES FOR AGE FROM MMS
Samples of
MMS

Estimated
AGE

---------------------20.0
70.889

22.0
24.0

26.0
28.0

68.944
67.000
65.056
63.111

SE of estimate = 5.4254
Linear equation= 90.33333 + (-.97222 >
AGE Mean= 67

*

Standard deviation= 5.7

MMS
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PAD Subjects by CDR
ANALYSIS OF VARIANCE
SUMMARY TABLE FOR MMS

VARIABLE

PALLAIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO

p

--------------------------------------------SEVERITY R = .62

.38

1

18.46 <.0005

df2 = 30
Notes: N = 32
Effect size is multiple correlation/eta (R).
Tests are two-tailed. For a one-tailed test, divide the p
of any variable w1th df = 1 by two IF the results are in
the predicted direction.
MMS
SEVERITY
CDRS
CDR1
MMS Mean

= 24

MEANS
MEAN
25.0000
22.7143

N

18
14

Standard dev1at1on

= 1.8
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PAD Subjects by P300 Z-Score
F TEST OF CORRELATION
SUMMARY TABLE FOR MMS
PALLAIEFFECT BARTLETT CHI SQ. OR
SIZE
V
DF1 F RATIO

VARIABLE
P3SD

.01

r = -.11

1

p
n. s.

.37

df2 = 30
Notes: N = 32
Effect size is product-moment correlation <r>.
Tests are two-tailed. For a one-tailed test, divide the p
of any variable with df = 1 by two IF the results are 1n
the predicted direction.
ESTIMATING SCORES FOR MMS FROM P3SD
Samples of
P3SD

.o

2.0
4.0
5.0
7.0

Estimated
MMS
24.308
24.117

23.926
23.831
23.640

SE of estimate = 1.8258
Linear equation= 24.30806 + (-9.5500000E-02 >
MMS Mean

=

24

Standard dev1at1on

=

1.8

*

P3SD
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Appendix C

*

Flow Chart of Evaluation Process

Stage 0:

Recruitment

Stage 1:

Initial Assessment
(Completed by the Public Health Nurse or
Clinic Therapist)

Stage II:

Primary Dementia Evaluation
Social work evaluation
Psychiatric Interview
mini-mental state exam
portion of Hachinski
Hamilton Depression Scale
Clinical Neuropsychological Evaluation
Neurolinguistic Evaluation
Blood, Urine, Lab tests
CT scan
EEG

Stage III:

Referral to Project
Neurological Evaluation
complete Hachinski
Review of data
Decision to include in study
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Stage IV:

Study Group
PET FDG Scan
Multivariate Memory Test
P300 Latency Recordings

*

Kuhl, D.E.

(1983), Emission computed tomography of local

cerebral functions, Unpublished grant proposal,
University of California, Los Angeles.
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Appendix D
Neuropsychological Battery
General Intelligence
Wechsler Adult Intelligence Scale
Memory
Benton Visual Retention Test (Benton, 1974)
Rey Auditory Verbal Learning Test (Rey, 1964)
Attention and Concentration
Number Cancellation Protocol (Lezak, 1983)
Smith Symbol-Digit Modalities Test (Smith, 1973)
Trail Making Test A and B
Test of Abstract Reasoning
Raven's colored Progressive Matrices
Test of Visuoconceptual Abilities
Hooper Visual Organization Test (Hooper, 1958)
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Appendix E
Clinical Dementia Rating Scale
The Clinical Dementia Rating (CDR)

scale utilized

information gathered through interviews to determine what
stage of dementia the patient has reached.
include:

questionable~

moderate or severe.

The stages
There are six

categories of functioning that are assessed which include:
memory, orientation, judgment/problem solving, community
affairs, home/hobbies and personal care
numerical ratings are as follows:

(see chart).

The

A score of 0 = healthy

functioning, no difficulties in any category; 0.5 =mild
impairment~

1.0 =moderate memory loss, mild

dementia~

2.0

= moderate dementia, severe memory loss and disorientation
to time or 3.0 = severe dementia, severe memory loss,
disorientation to person, and personal care minimal or
non-existent.
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A New Clinical Scale for the Staging of Dementia
Clinical dementia rating (CDR)
Healthy
CDR 0

Memory

No memory
loss or
slight
inconstant
forgetfulness

Orientation
Fully
oriented

Questionable dementia
CDR 0.5

Mild dementia
CDR 1. 0

Mild consistent
forgetfulness;
partial recollection
of events; 'benign'
forgetfulness

Moderate
memory loss
more marked
for recent
events;
defect
interferes
with everyday
activities

Fully
oriented

SomE:!
difficu,l ty
with time
relationships
oriented for
place and
person at
exam but may
have geo-·
graphic
disorienta-

Judgment/Problem Solving
Solves
Only doubtful
everyday
impairment in
problems
solving problems,
well;
similarities,
judgment
differences
good in
relation to
past performance

Moderate
difficulty in
handling
complex
problems;
social
judgment
usually
maintained
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CDR 0

CDR 0.5

CDR 1. 0

-------------------------------------------------------Community affairs
Independent Only doubtful or mild
function at impairment, if any in
usual level these activities
in job,
shopping,
business,
and financial
affairs,
volunteer
and social
groups

Home and Hobbies
Life at
home,
intellectual
interests
well
maintained

Personal care
Fully
capable
of self
care

Life at home, hobbies
intellectual interests
well maintained or
only slightly
impaired

Fully capable of
self care

Unable to
function
independently
at these
activities
though may
still be
engaged in
some; may
still appear
normal to
casual
inspection
Mild but
definite
impairment
of function
at home;
more
difficult
chores
abandoned;
more complicated hobbies
and interests
abandoned
Needs
occasional
prompting
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Moderate dementia

Severe dementia

CDR 2.0

CDR 3.0

Memory
Severe memory loss;
only highly learned
material retained;
new material
rapidly lost

Severe memory loss;
only fragments
remain

Usually disoriented
in time, often to
place

Orientation to
person only

Orientation

Judgment/problem solving
Severely impaired in
handling problems,
similarities,
differences; social
judgment
usually impaired
Community affairs
No pretense of
independent function
outside home

Unable to make
judgments or
solve problems

No pretense of
independent function
outside home

Home and hobbies
Only simple chores
No significant
function in home
preserved; very
restricted interests,
outside of own
poorly sustained
room
Personal care
Requires assistance
in dressing, hygiene,
keeping of personal
effects

Requires much help
with personal care;
often incontinent

CDR Score

---------------------
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Instructions for CDR
Use all information and make the best judgment.
Score each category as independently as possible.

Mark in

only one box, rating each according to subject's cognitive
function.

For determining the CDR, memory is considered

the primary category; all others are secondary.

If at

least three secondary categories are given the same
numerical score as memory, the CDR = memory.

If three or

more secondary categories are given a score greater or
less than the memory score, CDR = score of majority of
s~condary

categories, unless three secondary categories

are scored on one side of memory and two secondary
categories are scored on the other side of memory.

In

this last circumstance, CDR = memory.
When memory= 0.5, CDR= 1 if at least three of
certain others (Orientation, Judgment, Community Affairs,
Home and Hobbies) are scored 1.0 or greater (Personal care
is not influential here).

If Memory= 0.5, CDR cannot be

0, CDR can only be 0.5 or 1.0.

If memory = 1, CDR= 1

unless there is slight impairment in two or more secondary
categories, in which case CDR= 0.5.
Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A., &
Martin, R.L.,

(1982).

staging of dementia.
140, 566-572.

A new clinical scale for the
British Journal of Psychiatry,
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Appendix F
Mini-Mental State
The Mini-Mental State Exam (MMS) was developed by
Folstein, Folstein and McHugh (1975) as a formalized,
normed mental status exam consisting of 30 questions.
subsections of the

MMS include:

The

orientation, memory,

attention, expressive/receptive abilities and visuographic
tasks (see protocol).

The MMS is sensitive to changes in

cognitive impairment.

High scores (28-30) are indications

of little or no impairment.
to severe impairment.

Lower scores suggest moderate

An increase in the MMS score across

time occurs in reversible dementia.
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Patient's Name---------------Mini-Mental State

Test Date

by M.F. Folstein,

Testor Name

-----------------------------------------

S,E. Folstein, and
P.R. McHugh
Score

1 = correct
2

I.

=

incorrect

Orientation

Ask, "What is today's date?"

Date (e.g. Jan. 21) .. 1

Then ask specifically for

Year . . . . . . . . . . . . . . . . . 2

parts omitted; e.g., "Can

Month . . . . . . . . . . . . . . . . 3

you also tell me what season

Day (e.g. Monday) .... 4

it is?"

Season . . . . . . . . . . . . . . . 5

Ask, "Can you tell me the

Hospital . . . . . . . . . . . . . 6

name of this hospital?"

Floor . . . . . . . . . . . . . . . . 7

"What floor are we on?"
"What town (or city) are we

Town . . . . . . . . . . . . . . . . . 8

in?"
"What county are we in?"

County . . . . . . . . . . . . . . . 9____

"What state are we in?"

state . . . . . . . . . . . . . . . 1 0
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II.

Registration

Ask the subject if you may

"Ba 11 " ••••••••••••••

test his/her memory.

Then

"Flag" . . . . . . . . . . . . . . 12

say "ball," "flag," "tree"

"Tree" . . . . . . . . . . . . . . 13

11

clearly and slowly, about one
second for each.

After you have

said all 3, ask him/her to

Number of trials .... 14

repeat them.

(number 14 not included in

This first

repetition determines his/her

in score)

score (0-3) but keep saying
them until s/he can repeat all
3, up to 6 trials.

If s/he

does not eventually learn all 3,
recall cannot be meaningfully tested.
III.

Attention and Calculation

Ask the subject to begin with

"93" • . . . . . . . . . . . . . . . 15

100 and count backwards by 7.

'' 86 ,, . . . . . . . . . . . . . . . . 16

Stop after 5 subtractions

11

( 9 3, 8 6, 7 9, 7 2, 6 5) .

Score

the total number of correct

II

79 II

o

•

•

•

•

•

•

•

o

•

•

•

•

•

•

•

17

72 II

•

•

•

•

•

o

•

•

•

•

•

•

•

•

•

•

18

"65" ........•..••.•• 19

answers. If the subject cannot
or will not perform this task,
ask him/her to spell the word
"world" backwards.

The score is

the number of letters in correct order.
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For example, dlrow

=

5, dlorw

=

3,

Records how the subject spelled
"world" backwards

Number of letters in
d 1 o r w
correct order ...... 20
(include either number 19
or 20 in score)

IV.

Recall

Ask the subject to recall

"Ball" . . . . . . . . . . . . . 21

the 3 words you previously

"Flag" . . . . . . . . . . . . . 22

asked him/her to remember.

"Tree" . . . . . . . . . . . . . 23

Score 0-3.

v.

Language

naming:

Show the subject

a wrist watch and ask him/her
what it is.

Watch . . . . . . . . . . . . . . . 24
Penci 1 . . . . . . . . . . . . . 25

Repeat for

pencil.
repetition:

Ask the

subject to repeat,

Repetition . . . . . . . . . 26 ____

"No ifs,

and, or buts."
3-stage command:

Give

Takes paper in

the subject a piece of

in right hand ...... 27

plain blank paper and say,

Folds paper in

"Take the paper in your right

half . . . . . . . . . . . . 28
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hand, fold it in half and put

Puts paper on

it on the floor."

floor ............ 29

--------------------------------------------------------reading:

On a blank piece

of paper print the sentence,
"Close your eyes," in letters
large enough for the subject to
see clearly.

Ask him/her to read

it arid do what it says.

Score

correct only if s/he actually
closes his/her eyes.
writing:

Closes eyes ........ 30

Give the subject a

blank piece of paper and ask
him/her to write a sentence.
It is to be written spontaneously.
It must contain a subject and
verb and be sensible.

Correct

grammar and punctuation are
not necessary.
copying:

Writes sentence .... 31

On a clean piece of

paper, draw intersecting pentagons, each side about 1 inch, and
ask subject to copy it exactly as
it is.

All 10 angles must be

present and two must intersect to
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score 1 point.

Tremor and

rotation are ignored.

Draws pentagons .... 32

e.g.

Rate subject's level of consciousness
(a) coma
(b) stupor
(c) drowsy
(d) alert

33

(number 33 not included
in score)
TOTAL CORRECT
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Appendix G
Hachinski Ischemic Score
Hachinski et al.

(1975) studied cerebral blood flow of

24 patients in an attempt to differentiate demented
patients fr?m non-demented patients.

The variables

measured included blood flow through fast-clearing tissue
mainly gray matter (Ff); Blood flow through slow-clearing
tissue, white matter (Fs); the portion of tissue clearing
at the fast rate (Wf); flow measured from the slope of the
first two minutes of the logarithmically displayed isotope
clearance curve (F initial); and weighted mean flow (F).
Their results indicated that patients fell into two groups
with 10 patients scoring 7 and above on the Ischemic Scale
and 14 patients scoring 4 and below.

Patients with a

score of 7 and above were classified as having multiinfarct dementia.

Those with a score of 4 and below were

classified as having primary degenerative dementia.
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Clinical Features of Ischemic Scale
Score

Feature
Sudden onset

2

Stepwise deterioration

1

Fluctuating course

2

Nocturnal confusion

1

Relative preservation
of personality

1

Depression

1

Somatic complaints

1

Emotional incontinence

1

History of hypertension

1

History of strokes

2

Evidence of associated
atherosclerosis

1

Focal neurological
symptoms
Focal neurological signs

2
2

Hachinski, V.C., Iluff, L D., Phil M., Zilhka, E., Du
Boulay, G. H., McAllister, V.L., Marshall, J.,
Russell,

R.W.~.,

& Lyman, L (1975) Cerebral blood

flow in dementia, Archives of Neurology, 32, 632-637
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Appendix II
Epilogue
Following completion of this study, it became evident
that multiple runs are very important to ensure obtaining
the most clear P300 latency record possible.

Making sure

that at least two complete runs were obtained from each
patient and control would be one improvement that could be
made from the onset of the study.
For future studies it would be interesting to study
the P300 latency measures for each subsequent year in
order to discover if there are any patterns that might be
particular to Alzheimer's patients.

It may also be

informative to correlate these follow-up P300 latencies
with corresponding PET scans.

With this particular group

of subjects, analyses of memory, neuropsychological and/or
psycholinguistic data could also be completed and compared
with the initial P300 latency measures.
Furthermore, it would be advantageous to obtain PET
scans and P300 latency measurements on patients with
dementia secondary to Huntington's Disease, and compare
the findings with the Alzheimer's patients in order to
note similarities and differ~nces between the two groups.
It is known that both groups have prolonged P300
latencies, but different patterns of cerebral
degeneration.
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